<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C745868C-1A14-451E-90DA-D92FDE99B4CA"><gtr:id>C745868C-1A14-451E-90DA-D92FDE99B4CA</gtr:id><gtr:name>University Cheikh Anta Diop de Dakar</gtr:name><gtr:address><gtr:line1>BP 5005</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8F040A04-142E-43C9-BBAA-33D2D726CC93"><gtr:id>8F040A04-142E-43C9-BBAA-33D2D726CC93</gtr:id><gtr:name>The Statens Serum Institute (SSI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/97889367-1389-4ADD-96A8-E8D3579259E8"><gtr:id>97889367-1389-4ADD-96A8-E8D3579259E8</gtr:id><gtr:name>University of Jos</gtr:name><gtr:address><gtr:line1>PMB 2084</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/54F9413B-19F2-46DE-AFD4-245E4FB19B79"><gtr:id>54F9413B-19F2-46DE-AFD4-245E4FB19B79</gtr:id><gtr:name>Stellenbosch University</gtr:name><gtr:address><gtr:line1>Private Bag X1</gtr:line1><gtr:line2>19 Jonkershoek Road</gtr:line2><gtr:line3>Matieland</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/49FFE305-71E4-41B1-87AC-8E58220B1F28"><gtr:id>49FFE305-71E4-41B1-87AC-8E58220B1F28</gtr:id><gtr:name>Novartis Institutes for Biomedical Research (NIBR)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EA6D79B-D8F2-4357-B9ED-EE9ADC0C767B"><gtr:id>3EA6D79B-D8F2-4357-B9ED-EE9ADC0C767B</gtr:id><gtr:name>National Institute for Public Health and Environment (RIVM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8D6A87B-48C3-49DC-8D55-AA7203607683"><gtr:id>A8D6A87B-48C3-49DC-8D55-AA7203607683</gtr:id><gtr:name>University of British Columbia (UBC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/58930F3F-9B16-4DC2-833F-C72033E77A1E"><gtr:id>58930F3F-9B16-4DC2-833F-C72033E77A1E</gtr:id><gtr:name>Boston Children's Hospital</gtr:name><gtr:address><gtr:line1>Boston Childrens Hospital</gtr:line1><gtr:line2>Karp Building</gtr:line2><gtr:line3>9th floor, Rm 09210 1 Blackfan Circle</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/468F2797-5295-4912-BDED-8F3402CE246A"><gtr:id>468F2797-5295-4912-BDED-8F3402CE246A</gtr:id><gtr:name>New York University</gtr:name><gtr:address><gtr:line1>7 East 12th Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C745868C-1A14-451E-90DA-D92FDE99B4CA"><gtr:id>C745868C-1A14-451E-90DA-D92FDE99B4CA</gtr:id><gtr:name>University Cheikh Anta Diop de Dakar</gtr:name><gtr:address><gtr:line1>BP 5005</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8F040A04-142E-43C9-BBAA-33D2D726CC93"><gtr:id>8F040A04-142E-43C9-BBAA-33D2D726CC93</gtr:id><gtr:name>The Statens Serum Institute (SSI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/97889367-1389-4ADD-96A8-E8D3579259E8"><gtr:id>97889367-1389-4ADD-96A8-E8D3579259E8</gtr:id><gtr:name>University of Jos</gtr:name><gtr:address><gtr:line1>PMB 2084</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/54F9413B-19F2-46DE-AFD4-245E4FB19B79"><gtr:id>54F9413B-19F2-46DE-AFD4-245E4FB19B79</gtr:id><gtr:name>Stellenbosch University</gtr:name><gtr:address><gtr:line1>Private Bag X1</gtr:line1><gtr:line2>19 Jonkershoek Road</gtr:line2><gtr:line3>Matieland</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/49FFE305-71E4-41B1-87AC-8E58220B1F28"><gtr:id>49FFE305-71E4-41B1-87AC-8E58220B1F28</gtr:id><gtr:name>Novartis Institutes for Biomedical Research (NIBR)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EA6D79B-D8F2-4357-B9ED-EE9ADC0C767B"><gtr:id>3EA6D79B-D8F2-4357-B9ED-EE9ADC0C767B</gtr:id><gtr:name>National Institute for Public Health and Environment (RIVM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8D6A87B-48C3-49DC-8D55-AA7203607683"><gtr:id>A8D6A87B-48C3-49DC-8D55-AA7203607683</gtr:id><gtr:name>University of British Columbia (UBC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/58930F3F-9B16-4DC2-833F-C72033E77A1E"><gtr:id>58930F3F-9B16-4DC2-833F-C72033E77A1E</gtr:id><gtr:name>Boston Children's Hospital</gtr:name><gtr:address><gtr:line1>Boston Childrens Hospital</gtr:line1><gtr:line2>Karp Building</gtr:line2><gtr:line3>9th floor, Rm 09210 1 Blackfan Circle</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/468F2797-5295-4912-BDED-8F3402CE246A"><gtr:id>468F2797-5295-4912-BDED-8F3402CE246A</gtr:id><gtr:name>New York University</gtr:name><gtr:address><gtr:line1>7 East 12th Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E89DF462-9EA4-4042-B006-DC19F73B5B9E"><gtr:id>E89DF462-9EA4-4042-B006-DC19F73B5B9E</gtr:id><gtr:firstName>Beate</gtr:firstName><gtr:surname>Kampmann</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_A900_1122"><gtr:id>717F10D6-08A1-48FE-AAD6-9E0FFA4468EB</gtr:id><gtr:title>Vaccines &amp;amp; Immunity Research MRC Unit, The Gambia</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_A900_1122</gtr:grantReference><gtr:abstractText>The Vaccines &amp;amp; Immunity research at the MRC Unit, The Gambia extends from basic research into mechanisms of disease and immunity in young children to the development of tests in the field that can help with diagnosing certain infections. We also conduct vaccine trials to international standards, which can show that a vaccine is not only safe but also able to prevent a particular disease. We carry out laboratory and epidemiological studies to determine the organisms that are carried in the nose and throat before and after a vaccine is given to see the impact not only on the active disease but also on carriage, which is likely to be a prerequisite for disease in some instances. We provide the data of this work to the WHO and other partners to help estimate the effects of a certain intervention and to translate the research to policy and practice. We work closely with the national TB and malaria programs to inform them of any significant findings that have public health implications. We conduct analytical studies of vaccine coverage and inform the EPI program of potential problems and the benefits of implementing additional vaccines and we critically assess the impact of new vaccines on the immunity of existing ones. All of our work also aims to build capacity in the region and contribute datasets from Africa to international organisations.</gtr:abstractText><gtr:technicalSummary>Vaccines &amp;amp; Immunity represents one of the three identified key themes of research at the MRC Unit in The Gambia and is headed by Prof Kampmann. Our research portfolio within Vaccines &amp;amp; Immunity comprises the following three areas, which are headed up by 3 senior investigators: Infant Immunology (Dr E Clarke), Molecular Diagnostics (M. Antonio) and Tuberculosis research (J. Sutherland). 
Our research covers basic laboratory science, translational research and clinical trials from phase I to phase IV: 
1. we aim to understand basic immunological mechanisms of protection and susceptibility in children of different ages to a wide range of infectious diseases causing major morbidity and mortality in our regional context, such as TB, pneumonia, diarrhoea, congenital infections
2. we investigate mechanisms of carriage and invasion of a variety of bacterial pathogens (strep pneumo, staph aureus, haemophilus and other causes of neonatal bacterial infections). These results guide the development of protective vaccines and other interventions.
3. We conduct clinical trials at all clinical stages of vaccine development, aimed at preventing serious infections in resource-poor settings in particular (pneumococcal vaccines, T vaccines, HIV, malaria, polio)
Over the last 12 months, we have completed a large-scale phase 4 trial of intramuscular polio vaccination (Lancet Global health 2016) and started another pneumococcal vaccine trial. We have completed the evaluation of a novel preparation of a pneumococcal vaccine which has now progressed to licensure via the EMA. We have set up a platform for the conduct of maternal immunisation trials and led an international conference on the issue. Our basic research is describing the interactions between the neonatal microbiome and early immune responses and explores age-related development of innate immune mechanisms in vitro. The international collaborations have enabled us to establish a number of new immunological assays in the Unit. Please find detailed descriptions of projects in the Infant Immunology report and the TB-CC report.</gtr:technicalSummary><gtr:fund><gtr:end>2018-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>5292062</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of British Columbia</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Department of Pediatrics</gtr:department><gtr:description>British Columbia University</gtr:description><gtr:id>71807A74-68B3-41BB-853F-D7D0C46FF22E</gtr:id><gtr:impact>publication, presentation at international meeting, visibility</gtr:impact><gtr:outcomeId>56cf4c26485a85.68543889-1</gtr:outcomeId><gtr:partnerContribution>access to protocols</gtr:partnerContribution><gtr:piContribution>provided support for field sample collections and vaccinations, plus laboratory facilities</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Stellenbosch</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>Screen-TB</gtr:description><gtr:id>FBEB428F-DB75-41ED-BE58-738BF8DFDC72</gtr:id><gtr:impact>Recruitment of patients will not begin until mid-2016. Outputs will occur by 2019.</gtr:impact><gtr:outcomeId>5641e01be64f81.37068762-1</gtr:outcomeId><gtr:partnerContribution>Grant co-ordinator/PI</gtr:partnerContribution><gtr:piContribution>Dr. Sutherland is site-PI for a multi-site study on development of a rapid diagnostic test for TB. This involves recruitment of 200 patients with symptoms suggestive of TB but prior to diagnosis. These patients are then diagnosed for TB or other respiratory disorders (ORD) using GeneXpert and biomarkers for TB are determined. The second stage of the project will use 'real-time' finger-prick testing of patients at the outpatients clinic to validate our diagnostic test in a 'field' setting.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cape Town</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:department>Institute of Infectious Disease and Molecular Medicine (IIDMM)</gtr:department><gtr:description>IIDMM UCT</gtr:description><gtr:id>CBC46305-5D65-4136-840E-D889C21E55DC</gtr:id><gtr:impact>joint publications
joint grant applications</gtr:impact><gtr:outcomeId>BGcCH68zKDS-1</gtr:outcomeId><gtr:partnerContribution>access to lab and field</gtr:partnerContribution><gtr:piContribution>joint supervision of PhD students
academic links in the field of TB
grant money to UCT</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Public Health and Environment (RIVM)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Centre for Infectious Diseases, Epidemiology and Surveillance</gtr:department><gtr:description>RIVM Holland</gtr:description><gtr:id>7E5C1990-15AB-49F7-96FF-8B6E41DB1890</gtr:id><gtr:impact>1 manuscript submitted, 1 in preparation</gtr:impact><gtr:outcomeId>DfDshfFByYT-1</gtr:outcomeId><gtr:partnerContribution>facilitating Tec Transfer to MRC by hosting 2 technicians</gtr:partnerContribution><gtr:piContribution>analysis of samples at MRC using RIVM technology, following successful tec transfer from RIVM
results on pertussis of interest to RIVM epidemiologists</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Child Health</gtr:department><gtr:description>ICH London Goldblatt lab</gtr:description><gtr:id>BA40F959-EA58-4958-AE3B-F2FCB770CF3B</gtr:id><gtr:impact>1 shared PhD studentship, 
scientific workshop at MRC The Gambia
input into senior appointments</gtr:impact><gtr:outcomeId>RHwAr4v9KRJ-1</gtr:outcomeId><gtr:partnerContribution>scientific exchange re pneumococcal immunisation policies, practice and research, sharing of reagents and assay development</gtr:partnerContribution><gtr:piContribution>scientific exchange re pneumococcal immunisation policies, practice and research, sharing of reagents and assay development</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>New York University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Mtb antigen diversity</gtr:description><gtr:id>14EEF98F-6E5F-4F35-96D8-296D4A20646E</gtr:id><gtr:impact>2 publications and a presentation at Keystone TB meeting 2015</gtr:impact><gtr:outcomeId>HQ4Ms3veQEe-1</gtr:outcomeId><gtr:partnerContribution>In silico epitope prediction</gtr:partnerContribution><gtr:piContribution>Subject recruitment, all immunology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Mask Study</gtr:description><gtr:id>E7F09FD9-7E7A-417E-BEE0-24C468E9CB3A</gtr:id><gtr:impact>Publications pending. Multidisciplinary project including microbiology and immunology</gtr:impact><gtr:outcomeId>58aedfbcc15f99.18734987-1</gtr:outcomeId><gtr:partnerContribution>Provision of masks and analysis of all samples collected.</gtr:partnerContribution><gtr:piContribution>The Mask study involves analysis of TB transmission and thus use of our TB case-contact platform to correlate patient transmission with infection status of the contacts.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Statens Serum Institute (SSI)</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>Staten Serum Institute Denmark</gtr:description><gtr:id>F7FD0B04-766B-408F-8D69-EAAFDF8BFA28</gtr:id><gtr:impact>joint publications</gtr:impact><gtr:outcomeId>A6VLtZf6QTG-1</gtr:outcomeId><gtr:partnerContribution>availability of reagents to our research study</gtr:partnerContribution><gtr:piContribution>application of reagents in research studies</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Jos</gtr:collaboratingOrganisation><gtr:country>Nigeria, Federal Republic of</gtr:country><gtr:department>Department of Paediatrics</gtr:department><gtr:description>University of Jos, Nigeria</gtr:description><gtr:id>6D65BF8F-2A4B-4520-A829-CA7CC20F5D02</gtr:id><gtr:impact>Foundation Award MRC</gtr:impact><gtr:outcomeId>58b0ab40990756.55306493-1</gtr:outcomeId><gtr:partnerContribution>set up of validators cohorts for childhood TB research</gtr:partnerContribution><gtr:piContribution>A paediatrician form Jos is developing a research project under my supervision and received funding via Imperial College in 2016. He is now also a collaborator on the Foundation GCRF award</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Universit? Cheikh Anta Diop de Dakar, Dakar</gtr:collaboratingOrganisation><gtr:country>Senegal, Republic of</gtr:country><gtr:description>UCAD</gtr:description><gtr:id>DE2C9B08-AD15-4204-9F61-6A8E58E9C924</gtr:id><gtr:impact>scientific workshops</gtr:impact><gtr:outcomeId>58b0aa84d13e24.57477745-1</gtr:outcomeId><gtr:partnerContribution>exchange of ideas and potential for join grant applications</gtr:partnerContribution><gtr:piContribution>Professor Mboup and Professor Gaye are partners in our West African Global Health Research initiative and a number of members of their respective departments are now involved in our research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Division of Infectious Diseases</gtr:department><gtr:description>TB-CDRC</gtr:description><gtr:id>6A45E1F4-BEE5-4642-B199-BDE646A4C2F2</gtr:id><gtr:impact>consensus statement on TB diagnostics classification for children- see publications list</gtr:impact><gtr:outcomeId>Y6ewoFwQaGR-1</gtr:outcomeId><gtr:partnerContribution>regular input into paediatric study design and review of evolving concept sheets</gtr:partnerContribution><gtr:piContribution>I act a s the director of paediatric studies in this consortium which has a large grant from the NIH to conduct research into TB diagnostics</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cape Town</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>GC6-2013</gtr:description><gtr:id>1BC99D14-EDE9-4D61-9705-32510375209F</gtr:id><gtr:impact>2 consortium papers (Sutherland et al., 2013, CMI; Sutherland et al., 2013, Plos One).
RNA-seq data published in Lancet in 2016. 
Multi-disciplinary: epidemiology, clinical, immunological, microbiological</gtr:impact><gtr:outcomeId>R2qTZJu48Cu-1</gtr:outcomeId><gtr:partnerContribution>Securing funding and providing resources for RNA and plasma analysis.</gtr:partnerContribution><gtr:piContribution>Part of multi-site study for TB biomarkers. MRC recruited patients and their household contacts to generate incident cases - contacts who develop active TB within 2 years of recruitment. These subjects hold the key to understanding protective immunity to TB. RNA, plasma and PBMC are being analysed for biomarkers of TB 'risk'.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>University of Munich</gtr:description><gtr:id>363D7344-1B7A-489F-8219-DD7A89A47998</gtr:id><gtr:impact>the study is just starting, the website is being developed</gtr:impact><gtr:outcomeId>58b0abf572d295.14663104-1</gtr:outcomeId><gtr:partnerContribution>LMU is the grant holder and chose my TB program at MRC and the TBCC as a partner site in this 5-counry multicentre study.</gtr:partnerContribution><gtr:piContribution>Collaborative grant award from the German ministry to conduct research into lung sequelae of TB</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Oxford Vaccine Group</gtr:department><gtr:description>Oxford Vaccine Group</gtr:description><gtr:id>5B32B351-DD5D-49A4-9A42-27775754D302</gtr:id><gtr:impact>new collaboration</gtr:impact><gtr:outcomeId>54565254e40397.00524183-1</gtr:outcomeId><gtr:partnerContribution>joint supervision of PhD student</gtr:partnerContribution><gtr:piContribution>mutual engagement in Vaccinology research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis Institutes for BioMedical Research (NIBR)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Novartis Vaccines Institute for Global Health (NVGH)</gtr:department><gtr:description>Novartis Vaccine development</gtr:description><gtr:id>6262266B-5D4C-4E0D-AFD6-F1B0DCE731AD</gtr:id><gtr:impact>manuscript in progress</gtr:impact><gtr:outcomeId>YejVnqTre5E-1</gtr:outcomeId><gtr:partnerContribution>funding for consumables</gtr:partnerContribution><gtr:piContribution>generated data for pertussis seroprevalence</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boston Children's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Levy Laboratory</gtr:department><gtr:description>Levy Lab</gtr:description><gtr:id>91C1E1A0-7A21-4DBA-B5FC-303542E96D21</gtr:id><gtr:impact>several publications and a grant submission to the nIH</gtr:impact><gtr:outcomeId>56cf4bb1cea7e0.22270866-1</gtr:outcomeId><gtr:partnerContribution>bioinformatics support</gtr:partnerContribution><gtr:piContribution>set up of systems vaccinology research for studies of EPI vaccines</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Stellenbosch</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>AE-TBC</gtr:description><gtr:id>1E874180-2A2D-4B18-B20F-9C76AC912071</gtr:id><gtr:impact>1 manuscript to date: Ota et al., ERJ, 2014. 
Multi-disciplinary: immunology, clinical, microbiology</gtr:impact><gtr:outcomeId>nHSVk6iLZvo-1</gtr:outcomeId><gtr:partnerContribution>Equal numbers of recruitment and analyses</gtr:partnerContribution><gtr:piContribution>This was a multi-site study (7 African field-sites, 2 European partners) for development of a rapid TB test. MRC Gambia recruited and analysed 200 subjects.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Child Health</gtr:department><gtr:description>Harvard Levy lab</gtr:description><gtr:id>56E9CBF1-C6BF-4E9F-9360-1715382BF94C</gtr:id><gtr:impact>publication by Burl et al</gtr:impact><gtr:outcomeId>bKGtNvPjTDb-2</gtr:outcomeId><gtr:partnerContribution>contributed research samples</gtr:partnerContribution><gtr:piContribution>exchange of staff and technology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boston Children's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Harvard Levy lab</gtr:description><gtr:id>534ED31D-3DAE-4DA5-96E4-423F790FFC2E</gtr:id><gtr:impact>publication by Burl et al</gtr:impact><gtr:outcomeId>bKGtNvPjTDb-1</gtr:outcomeId><gtr:partnerContribution>contributed research samples</gtr:partnerContribution><gtr:piContribution>exchange of staff and technology</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>670FD79E-BA35-41AC-9526-7D23186BFA1E</gtr:id><gtr:impact>I was invited to speak at the Open Science week of a prestigious London School.
I have a talk on Ebola, which was well received. I had lunch with the students and many subsequent discussions arose.
Some have approached me since for questions how to get into medical school and how to go about a career in international health.</gtr:impact><gtr:outcomeId>56cf4f1823e453.37827398</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Inaugural lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>095AEC5F-9472-42FD-8EAD-3F69FF839233</gtr:id><gtr:impact>Travel with T cells, now on YouTube

inerest in academic medicine by GCSE-level students, several University students requesting mentorship</gtr:impact><gtr:outcomeId>Xtsp4briKxC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open Forum MRC</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>CAC4EF5A-A659-4DFD-A510-E08B89C9267A</gtr:id><gtr:impact>broader level of insight into the reserarch activities surrounding this theme, connecting up MRC and governmental activities

closer collaboration with National TB program and wider public support</gtr:impact><gtr:outcomeId>GfALY1fBje9</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>podcast</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BC2B35E0-6695-4ABC-9FD9-E86A426484BD</gtr:id><gtr:impact>this Imperial College podcast served to inform the audience about a recently published paper and my role was to put it in context of the wider scientific agenda in this area

facilitated interpretation of research findings to a wider audience</gtr:impact><gtr:outcomeId>mamusH29Bop</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MatImms App</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3227DB65-2F4F-49C6-81DF-195630F3146C</gtr:id><gtr:impact>we have designed an app to explain how vaccines work in pregnancy to women/interested people. this app can be downloaded free of charge from apple and android app stores.</gtr:impact><gtr:outcomeId>56cf4f999b4f05.22560799</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Opening a borehole</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>87A8C393-EE30-4855-9A11-7FC505DCD29B</gtr:id><gtr:impact>I sponsored a borehole to be built at one of our community sites and had the pleasure of handing it over to the community, which was much appreciated and featured on national radio throughout the day of the event and beyond.</gtr:impact><gtr:outcomeId>56cf509fe8ad54.18155264</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TB-sequel</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B15313D1-7212-4800-A48A-6C00203BDAAE</gtr:id><gtr:impact>Kick-off meeting for health systems networks which funds 5 projects in Africa for capacity building and development. The discussions generated new avenues for future funding and ideas for sustainability of the research networks.</gtr:impact><gtr:outcomeId>58aee7e44b15a6.62690630</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Immunology workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9E7766F9-281D-4650-9DCE-2D5BA4D47B93</gtr:id><gtr:impact>70 post-graduate students and 15 international faculty attended an immunology workshop for West Africa. This was the first time such an event had been held in the region and consisted of lectures and practical sessions. The students also presented posters with prizes for the top 3. The event was deemed highly successful and generated mentoring and networking.</gtr:impact><gtr:outcomeId>58aeed68da1150.37746512</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TB2016 conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DD4E57D6-5886-42BE-BBD4-7D27757C7AD9</gtr:id><gtr:impact>TB2016 was adjunct to AIDS2016 and was the first time a TB meeting was attached to the internationally renowned AIDS consortium. The meeting included policy makers, activists, researchers and patients from around the globe. This resulted in increased awareness of TB which is directly related to the AIDS epidemic.</gtr:impact><gtr:outcomeId>58aee6ee9878f4.93818188</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Project grant Polio trial BMGF</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:id>606D6AE7-9308-4971-A969-230BBCF4F0D2</gtr:id><gtr:outcomeId>545653cf3b6616.37873321</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>55000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Global Health Wellcome Trust fellowship Dr LeDoare</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>B6635081-34AB-467A-9F9D-96B490DE34A2</gtr:id><gtr:outcomeId>hwhABGkxAZN</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>247000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Research Training Fellowship</gtr:department><gtr:description>Wellcome Trust Training Fellowship</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>93B8B0A6-AAFA-4E4D-8EE6-FDD25D54D938</gtr:id><gtr:outcomeId>545652d3bfa2b4.36985616</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC studentship Dr Togun</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D48CB565-CBFE-48A8-8E74-468DF53A1A99</gtr:id><gtr:outcomeId>bzNAFdSMFX2</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Clinical Trial</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:id>120210B9-EEF2-45BB-8B91-3BB0F1B107B3</gtr:id><gtr:outcomeId>545bd5328d1b92.44219484</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DGF</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>787FFB4C-BAE0-4EFB-B2C2-CA4EF6C494C9</gtr:id><gtr:outcomeId>58aed68a872024.58979357</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Al Thrasher Award</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>Thrasher Research Fund</gtr:fundingOrg><gtr:id>E17AE6EA-8578-42F6-B229-F4D6E1536BAD</gtr:id><gtr:outcomeId>545653808049c6.60624468</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3066638</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>European and Developing Countries Clinical Trials Partnership</gtr:department><gtr:description>Networks of Excellence EDCTP</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>0FFFEA4B-FBCF-4AF5-81C8-997BB5BE4B1E</gtr:id><gtr:outcomeId>58b0b894487804.51769408</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Multi-dose PcV 13 Clinical Trial PI</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Pfizer Inc</gtr:fundingOrg><gtr:id>5719E0D0-0E27-4F39-B3B1-9DDE9A8B3893</gtr:id><gtr:outcomeId>56cf4e590e7ca3.43898165</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship for Dr Basu-Roy</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>BAA86EDA-6916-4947-8359-957D6A6E42F0</gtr:id><gtr:outcomeId>ZvjjCTdn8Fo</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>370000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship Dr Battersby</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>52F245B5-552F-47DA-A88E-A8C5C37AC2BF</gtr:id><gtr:outcomeId>axe6hfX2brF</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC mid-career grant</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9F6CD409-CDAA-437B-B232-0A57C73CFA11</gtr:id><gtr:outcomeId>545f7048276142.36113002</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Bloomsbury Centre</gtr:department><gtr:description>Wellcome Trust Career Development Fellowship</gtr:description><gtr:end>2020-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>08B660CF-57B5-4186-A9D1-A0150AF74397</gtr:id><gtr:outcomeId>58b0b6c38b4f52.55229167</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>16000</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LAMP TB test</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Foundation for Innovative New Diagnostics (FIND)</gtr:fundingOrg><gtr:id>1EA8724F-EDAD-4400-B4C6-C7F84C0DD997</gtr:id><gtr:outcomeId>545f6fb73a4153.72628990</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1800000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>HIPC</gtr:description><gtr:end>2022-01-02</gtr:end><gtr:fundingOrg>National Institutes of Health Clinical Center</gtr:fundingOrg><gtr:id>207A6A03-34D4-43E1-A677-A74B46DA6991</gtr:id><gtr:outcomeId>58b0b6167790e7.79528818</gtr:outcomeId><gtr:sector>Hospitals</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship Dr Saikou Bah</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>12ED58B6-08BA-45E0-8A80-BE9E7862AB95</gtr:id><gtr:outcomeId>gB2pEF6XNe1</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Investigator initiated proposal</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:id>C58D68CB-6506-42CA-847D-0C2AD6B41D5E</gtr:id><gtr:outcomeId>545bd3510cb2d4.17008784</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>480000</gtr:amountPounds><gtr:country>Belgium, Kingdom of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>TBVAC2020</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>European Commission H2020</gtr:fundingOrg><gtr:id>DEC5D9F9-A065-4EB4-BE17-9B643829DB82</gtr:id><gtr:outcomeId>545f6f635e6d42.43262303</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>European and Developing Countries Clinical Trials Partnership</gtr:department><gtr:description>Screen-TB</gtr:description><gtr:end>2019-04-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>A63EEC0D-8624-4FC3-8F8D-CDAC7BAAF0CE</gtr:id><gtr:outcomeId>5641d4562a3113.99652962</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1800000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>BMBF</gtr:description><gtr:end>2021-06-02</gtr:end><gtr:fundingOrg>Government of Germany</gtr:fundingOrg><gtr:id>9AF73244-8E3E-44C2-970E-9847DCB3BE0F</gtr:id><gtr:outcomeId>5641d40b593ff2.21663186</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>PhD studentship Dr Egere</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Ludwig Maximilian University of Munich (LMU Munich)</gtr:fundingOrg><gtr:id>82465E7B-0BDE-4992-92DF-3497237BA0A6</gtr:id><gtr:outcomeId>igTps7dvsCr</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EU/IMI</gtr:description><gtr:end>2021-04-02</gtr:end><gtr:fundingOrg>European Union</gtr:fundingOrg><gtr:id>E94B0D29-A736-4846-891C-3C97CC34365E</gtr:id><gtr:outcomeId>58b0b5c5b2d022.25163926</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Al Thrasher Award</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Thrasher Research Fund</gtr:fundingOrg><gtr:id>3B8B6EBD-FB4A-49A7-B5A3-A4E6BA3D1068</gtr:id><gtr:outcomeId>56cf4dd9eb57e5.31168602</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Capital funds</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>71B61007-EB56-47C5-A966-823190AE3EF1</gtr:id><gtr:outcomeId>545f6ffcf07280.92149424</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>work cited in international guidelines</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>31FFE53F-497A-4820-8C28-63C1D9B014BA</gtr:id><gtr:impact>rational use of resources</gtr:impact><gtr:outcomeId>sLjZBuUaHBp</gtr:outcomeId><gtr:type>Citation in systematic reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Pfizer GAVI advisory board</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>598B44FC-CF60-4B27-B033-3FED98409B8C</gtr:id><gtr:impact>possible impact, as Nigeria haas now introduced the PcV vaccine which was advised by the board</gtr:impact><gtr:outcomeId>qfigr2RKRKf</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NIH case-definition workshop</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5C49D02F-FA91-4FDB-89F9-9C99969723A0</gtr:id><gtr:outcomeId>jqBhv16EVSX</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Press panel RCPCH</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9A177BD4-0312-42D8-B23B-C4B2092AD6E3</gtr:id><gtr:outcomeId>tCBomKswfMn</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO advisory board</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>ABC3E5DB-442C-494E-BB93-87F6936349A3</gtr:id><gtr:impact>improvements in delivery of clinical services to children exposed to TB by advocating contact tracing for vulnerable groups in the WHO guideline document to which I contributed</gtr:impact><gtr:outcomeId>c53US1AyxbG</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>introduction of new vaccine in The Gambia EPI</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>4B51C9F8-C9E5-4808-A58F-5AA85E536996</gtr:id><gtr:impact>In August 2013 the Government of The Gambia introduced the Rotavirus vaccine into the EPI schedule. This was amongst other things prompted by data from the MRC Unit showing that rotavirus made a significant contribution to morbidity and mortality in children in The Gambia. The lab work was led by Vaccinology (Dr Antonio)</gtr:impact><gtr:outcomeId>EuoJ5ASurH2</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO pre-qualification of a vaccine tested in the Gambia</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>FFF1E903-4FC9-44DD-BFF5-A663DE2EA5BB</gtr:id><gtr:impact>The licensure of the novel preparation of the conjugated pneumococcal vaccine willed to more affordable and wide distribution f this vaccine- Impact should be tangible in the next few years. WHO pre-qualification occurred because of the trial conducted by the Vaccines &amp;amp; Immunity Theme.</gtr:impact><gtr:outcomeId>58b0bb2e467a28.95075205</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.mrc.ac.uk/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ECDC advocacy workshop</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>EF5EC723-060A-4B0B-A221-8887CD41DE04</gtr:id><gtr:impact>Raising the profile of paediatric tuberculosis in international organisations such as ECDC and WHO has led to the inclusion of recommendations specifically for children in the guidelines.</gtr:impact><gtr:outcomeId>D919epUH1Ko</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>guidelines for use of IGRA in children</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E5BC1740-063E-425E-A374-D0D77C2D4BA1</gtr:id><gtr:impact>our research has clearly identified the correct use of IGRA for the the diagnosis of TB in children. We were commissioned to publish our guidelines in a UK Education?actice Journal, which has an international audience</gtr:impact><gtr:outcomeId>ZdQfLvmap8r</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Introduction of MenAfriVac vaccine in the Gambia</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2DCE5844-E708-4E5A-8E7B-0563CB5C51B7</gtr:id><gtr:impact>Following our multi-centre clinical trial for the safety and immunogenicity of the MenAfriVac vaccine, a vaccine against meningitis A, this vaccine is now introduced into he national immunisation schedule</gtr:impact><gtr:outcomeId>56d1a76f0abd93.48903227</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Novartis maternal immunisation strategy board</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>F70A178F-AD7A-4468-A9A2-B06315EA9EAF</gtr:id><gtr:impact>the advice from the group of which I was an scientific member led to critical appraisal within industry which vaccines to push forward for maternal immunisation.</gtr:impact><gtr:outcomeId>NecBRT1mmNa</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>New classification of childhood tuberculosis</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>4D4FA886-622C-452A-BE53-95D3812893C4</gtr:id><gtr:impact>the NIH-commissioned workshop of which I was an invited member drafted a new case classification for research in childhood tuberculosis. This classification is now standard to attract funding for diagnostic-related research in this area.</gtr:impact><gtr:outcomeId>U75ZeRknkKD</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>We conducted a clinical trial for an alternative formulation of a licensed vaccine</gtr:description><gtr:id>B16B1D53-3C4D-4A08-ADF3-B0E3BC6DE0B8</gtr:id><gtr:impact>GAVI supported</gtr:impact><gtr:outcomeId>54565c092f02b3.58740290</gtr:outcomeId><gtr:stage>Market authorisation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Multi-dose PCV preparation</gtr:title><gtr:type>Therapeutic Intervention - Vaccines</gtr:type><gtr:ukcrnIsctnId>1234568</gtr:ukcrnIsctnId><gtr:yearDevCompleted>2014</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>2 needleless devices to administer vaccines are currently under evaluation within Vaccinology/Inf Immunology.
funding: BMGF/PATH</gtr:description><gtr:id>A98E0AED-0B3F-454B-BD01-A5B652F36EEE</gtr:id><gtr:impact>trial ongoing</gtr:impact><gtr:outcomeId>qW83WGDJ22y</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development_distribution</gtr:status><gtr:title>polio needleless devices</gtr:title><gtr:type>Therapeutic Intervention - Medical Devices</gtr:type><gtr:url>http://clinicaltrials.gov/show/NCT01847872</gtr:url><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>currently conducting new application of polio vaccine to be given i.m at 9 months with other EPI vaccines
funding: BMGF</gtr:description><gtr:id>1F701F1D-E730-44E0-9DEB-9DD01D825516</gtr:id><gtr:impact>trial in progress</gtr:impact><gtr:outcomeId>iXbaGgejQ7q</gtr:outcomeId><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Under active development_distribution</gtr:status><gtr:title>polio vaccine</gtr:title><gtr:type>Therapeutic Intervention - Vaccines</gtr:type><gtr:url>http://clinicaltrials.gov/show/NCT01847872</gtr:url><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>the trial assessed if the co-administration of inactive polio (IPV) with routine vaccines given at 9 months of age would impact on the immunogenicity of any of the vaccines administered. We found some concerns re rubella and yellow fever titres, but whether they are clinically significant remains to be established- the publication is under review</gtr:description><gtr:id>05222017-B49C-46CB-816C-E76F4603CA2A</gtr:id><gtr:impact>the policy re polio was influenced by the preliminary data we presented to the WHO and the IPV vaccine is now recommended to be administered at 4 months rather than 9 months of age.</gtr:impact><gtr:outcomeId>56cf5602daa2c5.79520477</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>polio interference trial</gtr:title><gtr:type>Therapeutic Intervention - Vaccines</gtr:type><gtr:yearDevCompleted>2015</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>designed an app tool to improve uptake of maternal immunisation</gtr:description><gtr:id>58F400BB-ECE6-4D67-86CD-A753EE1888C6</gtr:id><gtr:impact>this tool is publicly available fro the app store and is not restricted to researchers</gtr:impact><gtr:outcomeId>56cf5388931603.89903990</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>app</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>the contact tracing model was developed by my TB research group to facilitate the linking of index cases to childhood contacts. it has been developed in collaboration with public health england and an adapted version also in use at the MRC Unit in The Gambia.</gtr:description><gtr:id>B8603719-8A0C-47DC-96DF-EF9D0CA934D4</gtr:id><gtr:impact>contact tracing and chemoprophylaxis for children is now part of the activities of the National TB program in the Gambia</gtr:impact><gtr:outcomeId>pm8jmT4HUPV</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>design of a public health contact tracing model for TB control in the community</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>app to inform pregnant women about vaccines to be given in pregnancy and how they work</gtr:description><gtr:id>08269172-E894-4A73-987E-4996B579A55C</gtr:id><gtr:impact>only just launched</gtr:impact><gtr:outcomeId>56cf5652b6f1f8.31619787</gtr:outcomeId><gtr:title>MatImms app</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>04286C5E-AFB1-424E-AE76-F69A10C0A7B3</gtr:id><gtr:title>Recent Developments and Future Opportunities in the Treatment of Tuberculosis in Children.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff0ce7c349f66f838975792025ead9f1"><gtr:id>ff0ce7c349f66f838975792025ead9f1</gtr:id><gtr:otherNames>Seddon JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>56cf4a9acc27f9.33883015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CECB313-59F0-45F9-80F2-C3D45F4252E9</gtr:id><gtr:title>Sex-Differential Non-Vaccine-Specific Immunological Effects of Diphtheria-Tetanus-Pertussis and Measles Vaccination.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f0d00d6e320109e2364260747ad667c"><gtr:id>5f0d00d6e320109e2364260747ad667c</gtr:id><gtr:otherNames>Noho-Konteh F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>58aee1c39bd962.18376940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F8DB062-E351-4F97-9A38-4C88314AD96C</gtr:id><gtr:title>Dysregulation of Apoptosis Is a Risk Factor for Tuberculosis Disease Progression.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4343631aee7697faab563179dbe32c1"><gtr:id>a4343631aee7697faab563179dbe32c1</gtr:id><gtr:otherNames>Elliott TO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5641c8b7195517.68893365</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37C4876B-1E6E-450A-96F3-4B95E6467D61</gtr:id><gtr:title>No added value of interferon-? release to a prediction model for childhood tuberculosis.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20cdfef2eadb068c553328286c9523b5"><gtr:id>20cdfef2eadb068c553328286c9523b5</gtr:id><gtr:otherNames>Togun TO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>56cf4a9e349f50.46296639</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DED0EA95-363C-4BE4-BC84-1E090E2A3996</gtr:id><gtr:title>Paediatric emergency care in resource-limited settings.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91890f7a1b667277c672c547c0673a1d"><gtr:id>91890f7a1b667277c672c547c0673a1d</gtr:id><gtr:otherNames>Pollock L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_13512_22_23601944</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6664BE6-2B12-42D3-AB58-2211477914E8</gtr:id><gtr:title>Serogroup W135 meningococcal disease, The Gambia, 2012.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16027f09a1b1e435dac44e980eb7c9a1"><gtr:id>16027f09a1b1e435dac44e980eb7c9a1</gtr:id><gtr:otherNames>Hossain MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>pm_13512_22_23965435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C963D68-1FA3-4AEF-825F-9435E1042566</gtr:id><gtr:title>Contribution of Xpert&amp;reg; MTB/RIF to the diagnosis of pulmonary tuberculosis among TB-exposed children in The Gambia.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20cdfef2eadb068c553328286c9523b5"><gtr:id>20cdfef2eadb068c553328286c9523b5</gtr:id><gtr:otherNames>Togun TO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>5641c8b746af22.38189039</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>362082B4-95CC-423C-AD29-1679D75C2762</gtr:id><gtr:title>Tuberculosis in young refugees.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad775efcab9e8ebd79fe6cedaff47818"><gtr:id>ad775efcab9e8ebd79fe6cedaff47818</gtr:id><gtr:otherNames>Ritz N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>56cf4a43e9a382.21122319</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1CDF2D9-57CB-414A-A12D-A7241566129B</gtr:id><gtr:title>The first phylogeographic population structure and analysis of transmission dynamics of M. africanum West African 1--combining molecular data from Benin, Nigeria and Sierra Leone.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2765a26bdd37caa8fbd71943ba6d74a8"><gtr:id>2765a26bdd37caa8fbd71943ba6d74a8</gtr:id><gtr:otherNames>Gehre F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545f6d794577c7.46542025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1633E94-EAD9-4CFA-9018-38306CD8436A</gtr:id><gtr:title>Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cba970d198dea4055118b89c749afde"><gtr:id>1cba970d198dea4055118b89c749afde</gtr:id><gtr:otherNames>Cuevas LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_13512_22_22476719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40620B19-45D4-4C9E-BB11-4A7CFAD2D117</gtr:id><gtr:title>Analysis of LAM and 38 kDa Antibody Levels for Diagnosis of TB in a Case-Control Study in West Africa</gtr:title><gtr:parentPublicationTitle>ISRN Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/545e39189b54aa104dae1e0f2982a994"><gtr:id>545e39189b54aa104dae1e0f2982a994</gtr:id><gtr:otherNames>Gomez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>cFi7Mwgnu1w</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D80092B9-858B-4576-8752-F3162B3FA61B</gtr:id><gtr:title>Anti-group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2918f0e3820429f15952099f7448aa4"><gtr:id>f2918f0e3820429f15952099f7448aa4</gtr:id><gtr:otherNames>Le Doare K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>56cf4a9d4e5694.79030154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A83E4D6-30C1-403C-B900-07327328CFE0</gtr:id><gtr:title>Factors influencing innate immunity and vaccine responses in infancy.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cda45a6a26a4e43dac5e1b063bbf789a"><gtr:id>cda45a6a26a4e43dac5e1b063bbf789a</gtr:id><gtr:otherNames>Kampmann B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>56cf4a9b8781a0.71939197</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F6EEF73-E0ED-4533-8F7E-72BAD8AFE98D</gtr:id><gtr:title>Antibody and T-cell responses during acute and convalescent stages of invasive pneumococcal disease.</gtr:title><gtr:parentPublicationTitle>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbd9cb794d60ad6017c8b7d55cbd8f5d"><gtr:id>bbd9cb794d60ad6017c8b7d55cbd8f5d</gtr:id><gtr:otherNames>Ota MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1201-9712</gtr:issn><gtr:outcomeId>jbNUmQ2XBUZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1F935A4-D6D2-43EC-849C-870F343A8DD7</gtr:id><gtr:title>Non-tuberculous mycobacteria in children: muddying the waters of tuberculosis diagnosis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ec537c5d18a4442d5c2085be8cdbeb0"><gtr:id>2ec537c5d18a4442d5c2085be8cdbeb0</gtr:id><gtr:otherNames>L?pez-Varela E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>56cf4a9c69a6a4.37351816</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E10BEB46-4E4B-42F6-9BDC-BFC1A54A2EFA</gtr:id><gtr:title>Comparison of mucosal lining fluid sampling methods and influenza-specific IgA detection assays for use in human studies of influenza immunity.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7219e699c28c45d6e339476809f7f10"><gtr:id>c7219e699c28c45d6e339476809f7f10</gtr:id><gtr:otherNames>de Silva TI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>5a9eed066d7a98.53044903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AC89C6E-A151-4EC5-893D-04D309D8EAB5</gtr:id><gtr:title>Immunogenic Mycobacterium africanum strains associated with ongoing transmission in The Gambia.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2765a26bdd37caa8fbd71943ba6d74a8"><gtr:id>2765a26bdd37caa8fbd71943ba6d74a8</gtr:id><gtr:otherNames>Gehre F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>pm_23588_28_24050158</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF573940-B330-4B38-A96F-70BB5FDE801D</gtr:id><gtr:title>Embracing the challenges of HIV-TB co-infection in children.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a9050d5956f85b865bf30ed8ee0537a"><gtr:id>1a9050d5956f85b865bf30ed8ee0537a</gtr:id><gtr:otherNames>van Leth F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>545bcfec183a29.02677474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88B4F208-2F1F-4749-A915-C19227D733A8</gtr:id><gtr:title>Availability and use of molecular microbiological and immunological tests for the diagnosis of tuberculosis in europe.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a420a8e982eed89eac394624414ca069"><gtr:id>a420a8e982eed89eac394624414ca069</gtr:id><gtr:otherNames>Tebruegge M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545bcf9ab5bf87.48140214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>082A840B-30B0-4C23-BBD6-E81255DE57B6</gtr:id><gtr:title>Short communication: prevalence of antibodies against Coxiella burnetii (Q fever) in children in The Gambia, West Africa.</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e32f50185a50d4fb1d6cac7c7f40e42c"><gtr:id>e32f50185a50d4fb1d6cac7c7f40e42c</gtr:id><gtr:otherNames>van der Hoek W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn><gtr:outcomeId>pm_13512_22_23600611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>220BA60F-80A7-4518-8C52-B3D768F91F6D</gtr:id><gtr:title>Antibodies against Haemophilus influenzae type b in The Gambia: investigating the extent of protection across age groups.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8630d38a88c3f539cee58b8275068ee2"><gtr:id>8630d38a88c3f539cee58b8275068ee2</gtr:id><gtr:otherNames>Idoko OT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>54564f09e14cc3.35779914</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EC9BEEA-4903-496F-AF3B-32F31C675C94</gtr:id><gtr:title>Specific antibodies against vaccine-preventable infections: a mother-infant cohort study.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb717bce2e3d9f5f8e2e0fd9de5431d0"><gtr:id>eb717bce2e3d9f5f8e2e0fd9de5431d0</gtr:id><gtr:otherNames>Jones C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>pm_13512_22_23585389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>905A7236-3452-4803-B3A7-B524F745E78F</gtr:id><gtr:title>Management of paediatric tuberculosis in leading UK centres: unveiling consensus and discrepancies.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c159370750a8c30de0c07f31162d2e5"><gtr:id>4c159370750a8c30de0c07f31162d2e5</gtr:id><gtr:otherNames>Turkova A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>545bcf9a8d2488.01897905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8457F18-313A-4CB3-8A56-03DD87F423F7</gtr:id><gtr:title>Neonatal admissions, quality of care and outcome: 4 years of inpatient audit data from The Gambia's teaching hospital.</gtr:title><gtr:parentPublicationTitle>Paediatrics and international child health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b991a05bb435b0d9b82486d5bf925bc6"><gtr:id>b991a05bb435b0d9b82486d5bf925bc6</gtr:id><gtr:otherNames>Okomo UA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2046-9047</gtr:issn><gtr:outcomeId>56cf4a454609d7.42554433</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDD1059F-279F-4D0E-BDB9-C0DD028C4E82</gtr:id><gtr:title>Understanding pneumococcal serotype 1 biology through population genomic analysis.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8807bf0f44f87a6f8a2d52384229dfcd"><gtr:id>8807bf0f44f87a6f8a2d52384229dfcd</gtr:id><gtr:otherNames>Chaguza C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>58c98ae09ecaa2.04541506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DFF6A90-7762-47FF-8401-12C43807F3B7</gtr:id><gtr:title>The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Gu&amp;eacute;rin vaccination.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bdffc049adbcb99401d65c52e5ff669"><gtr:id>3bdffc049adbcb99401d65c52e5ff669</gtr:id><gtr:otherNames>Jones CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>56cf4a9dc7ca24.38443287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BD537EB-F048-4A7D-93FB-C2A0F107E4EE</gtr:id><gtr:title>Acceptance of multiple injectable vaccines in a single immunization visit in The Gambia pre and post introduction of inactivated polio vaccine.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8630d38a88c3f539cee58b8275068ee2"><gtr:id>8630d38a88c3f539cee58b8275068ee2</gtr:id><gtr:otherNames>Idoko OT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>58b0b54d38e312.93563643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>472E117C-F7C3-48F6-81A1-3715507C1FC1</gtr:id><gtr:title>The influence of paediatric HIV infection on circulating B cell subsets and CXCR5(+) T helper cells.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3da9d74f94d2e484bd71b0b6e6e2f9d6"><gtr:id>3da9d74f94d2e484bd71b0b6e6e2f9d6</gtr:id><gtr:otherNames>Bamford A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>56cf4a9a8e46e2.14674233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B227EC64-0E53-4B06-A19F-965285DED8F1</gtr:id><gtr:title>Differences in T-cell responses between Mycobacterium tuberculosis and Mycobacterium africanum-infected patients.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2ecf50e86c7e8e51297ab5a17dc502c"><gtr:id>f2ecf50e86c7e8e51297ab5a17dc502c</gtr:id><gtr:otherNames>Tientcheu LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>545bd09798cf83.82588365</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9E641D7-4B74-45D3-9537-C91F54AC30E7</gtr:id><gtr:title>Childhood tuberculosis is associated with decreased abundance of T cell gene transcripts and impaired T cell function.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a9136959e410b91bf6d047213a4f31f"><gtr:id>4a9136959e410b91bf6d047213a4f31f</gtr:id><gtr:otherNames>Hemingway C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a9eed04df9b56.79544154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFF72B11-495C-4253-A24F-9EE6DD907C41</gtr:id><gtr:title>Associations between nasopharyngeal carriage of Group B Streptococcus and other respiratory pathogens during early infancy.</gtr:title><gtr:parentPublicationTitle>BMC microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6ef0759dc8a0d2f9e7e260ed349f798"><gtr:id>e6ef0759dc8a0d2f9e7e260ed349f798</gtr:id><gtr:otherNames>Foster-Nyarko E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2180</gtr:issn><gtr:outcomeId>58b0b54e8e1c43.36238160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>430A0E68-378C-4C20-B504-2AE5EE8E1D95</gtr:id><gtr:title>Differential transcriptomic and metabolic profiles of M. africanum- and M. tuberculosis-infected patients after, but not before, drug treatment.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2ecf50e86c7e8e51297ab5a17dc502c"><gtr:id>f2ecf50e86c7e8e51297ab5a17dc502c</gtr:id><gtr:otherNames>Tientcheu LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>5641c862ada390.19482673</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9DEB732-8308-45CE-ABA1-BE4708B77D5E</gtr:id><gtr:title>Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.</gtr:title><gtr:parentPublicationTitle>Clinical and vaccine immunology : CVI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c84a57e2de07c209dc3eb51a68b9fb94"><gtr:id>c84a57e2de07c209dc3eb51a68b9fb94</gtr:id><gtr:otherNames>Fletcher HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1556-679X</gtr:issn><gtr:outcomeId>pm_13512_22_23986316</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74081D0B-5C69-4717-A2DB-3B1A99372EDD</gtr:id><gtr:title>Breast milk and Group B streptococcal infection: vector of transmission or vehicle for protection?</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2918f0e3820429f15952099f7448aa4"><gtr:id>f2918f0e3820429f15952099f7448aa4</gtr:id><gtr:otherNames>Le Doare K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>54565039784582.12337305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F779456-B4F0-4236-B4E1-64CC56F50379</gtr:id><gtr:title>IL-17 Production from T Helper 17, Mucosal-Associated Invariant T, and ?d Cells in Tuberculosis Infection and Disease.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3f7bbbedddc2abc66772e2cf6dc4233"><gtr:id>f3f7bbbedddc2abc66772e2cf6dc4233</gtr:id><gtr:otherNames>Coulter F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a9eed0568a811.18589901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B846A311-6C93-4243-8E6F-C16EC3E710DC</gtr:id><gtr:title>The Immunogenicity of Fractional Intradermal Doses of the Inactivated Poliovirus Vaccine Is Associated With the Size of the Intradermal Fluid Bleb.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bc02dfd10b5ed3768377a6628c07e55"><gtr:id>3bc02dfd10b5ed3768377a6628c07e55</gtr:id><gtr:otherNames>Bibby J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>5aaa3e0324f789.49608110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49E129F5-B1F7-44C8-8640-9D87D9AB622F</gtr:id><gtr:title>Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2ecf50e86c7e8e51297ab5a17dc502c"><gtr:id>f2ecf50e86c7e8e51297ab5a17dc502c</gtr:id><gtr:otherNames>Tientcheu LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>58aee1c453dc29.93696433</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7273E93F-983B-46AA-A520-3A502B27FA04</gtr:id><gtr:title>Sequence diversity in the pe_pgrs genes of Mycobacterium tuberculosis is independent of human T cell recognition.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa50494ebb1a33b6be4cdb6d7a4b83b5"><gtr:id>fa50494ebb1a33b6be4cdb6d7a4b83b5</gtr:id><gtr:otherNames>Copin R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5641c9b4232987.18725322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F16E7DA9-3094-4037-BF48-E2091B3D0484</gtr:id><gtr:title>Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c721e059d2551533a2a9aa5e0ffde77b"><gtr:id>c721e059d2551533a2a9aa5e0ffde77b</gtr:id><gtr:otherNames>Sutherland JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_23588_28_24040170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9B3FB21-08F8-4D8D-A91C-DDBBAA1083FC</gtr:id><gtr:title>Early phase clinical trials with human immunodeficiency virus-1 and malaria vectored vaccines in The Gambia: frontline challenges in study design and implementation.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bd0b08c7569d3fbb892d3070c540098"><gtr:id>5bd0b08c7569d3fbb892d3070c540098</gtr:id><gtr:otherNames>Afolabi MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn><gtr:outcomeId>545bcfec8a23e8.24467939</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D20D7405-242F-4EB7-B1C4-841520684AF3</gtr:id><gtr:title>Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3da9d74f94d2e484bd71b0b6e6e2f9d6"><gtr:id>3da9d74f94d2e484bd71b0b6e6e2f9d6</gtr:id><gtr:otherNames>Bamford A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>54564f8e488d78.84208837</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74196C8F-DA1F-410C-8436-19ECBA836504</gtr:id><gtr:title>Value of immunogenicity studies of influenza vaccine in resource-limited settings.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7219e699c28c45d6e339476809f7f10"><gtr:id>c7219e699c28c45d6e339476809f7f10</gtr:id><gtr:otherNames>de Silva TI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>58b0ad63043458.97217006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29DEE609-B847-4EBC-ACBE-D20C739D801E</gtr:id><gtr:title>Evaluating UK National Guidance for Screening of Children for TB: A Prospective Multi-centre Study.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cda45a6a26a4e43dac5e1b063bbf789a"><gtr:id>cda45a6a26a4e43dac5e1b063bbf789a</gtr:id><gtr:otherNames>Kampmann B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>5a9eecc4b94040.42135911</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E27A9B5D-987D-4629-AABC-58C0FFB145E5</gtr:id><gtr:title>Complex anemia in tuberculosis: the need to consider causes and timing when designing interventions.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/109444a10d09e9ed58baf403ba7c3ac8"><gtr:id>109444a10d09e9ed58baf403ba7c3ac8</gtr:id><gtr:otherNames>Minchella PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>5641c8b67705e6.36827993</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F0D7605-FE2B-4E62-BA25-9243E4DC0308</gtr:id><gtr:title>Isolation of Methicillin-resistant Staphylococcus aureus and Multidrug-resistant Elizabethkingia meningoseptica From Neonates Within Minutes of Birth.</gtr:title><gtr:parentPublicationTitle>The Pediatric infectious disease journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c321d78409ed6f6822fa72581eb5a17"><gtr:id>5c321d78409ed6f6822fa72581eb5a17</gtr:id><gtr:otherNames>Kwambana-Adams BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0891-3668</gtr:issn><gtr:outcomeId>58c98adeee1472.05229541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6347561E-E29D-42AC-A1C9-148EEF2B996E</gtr:id><gtr:title>Azithromycin in Labor Lowers Clinical Infections in Mothers and Newborns: A Double-Blind Trial.</gtr:title><gtr:parentPublicationTitle>Pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09d65a9f2d3d277704045dd877dc92a0"><gtr:id>09d65a9f2d3d277704045dd877dc92a0</gtr:id><gtr:otherNames>Oluwalana C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0031-4005</gtr:issn><gtr:outcomeId>58b0ad63655904.94351342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>176E8F9F-BB26-463E-B878-76BA0EDEA58C</gtr:id><gtr:title>Why the Convention on the Rights of the Child must become a guiding framework for the realization of the rights of children affected by tuberculosis.</gtr:title><gtr:parentPublicationTitle>BMC international health and human rights</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb1713935960ba4e6ada861507a76d09"><gtr:id>bb1713935960ba4e6ada861507a76d09</gtr:id><gtr:otherNames>Basu Roy R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1472-698X</gtr:issn><gtr:outcomeId>58b0a99a3d6072.47716200</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E100F95D-9114-4F37-A231-D6732DAA2F9B</gtr:id><gtr:title>Digitised audio questionnaire for assessment of informed consent comprehension in a low-literacy African research population: development and psychometric evaluation.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bd0b08c7569d3fbb892d3070c540098"><gtr:id>5bd0b08c7569d3fbb892d3070c540098</gtr:id><gtr:otherNames>Afolabi MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>545f6c3e332314.54599590</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77D8014B-B30A-40E8-8F16-4BBE7BF34713</gtr:id><gtr:title>Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/914a5d9d73e66a78a254c31b21274506"><gtr:id>914a5d9d73e66a78a254c31b21274506</gtr:id><gtr:otherNames>Graham SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_13512_22_22448023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74339622-9D9E-4648-802F-8DA2BDAA9AF5</gtr:id><gtr:title>Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2a9060505e9c79a97edbc43c3c65347"><gtr:id>c2a9060505e9c79a97edbc43c3c65347</gtr:id><gtr:otherNames>Odutola A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5a9eed07d61aa9.43891907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F61B5D91-B786-4D2C-A6AF-AC07200FB31C</gtr:id><gtr:title>Negative Correlation between Circulating CD4FOXP3CD127Regulatory T Cells and Subsequent Antibody Responses to Infant Measles Vaccine but Not Diphtheria-Tetanus-Pertussis Vaccine Implies a Regulatory Role.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/729ba36d5705e40f5e7c40bd94950457"><gtr:id>729ba36d5705e40f5e7c40bd94950457</gtr:id><gtr:otherNames>Ndure J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5aaa3e03709330.25873756</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F69C75AC-CE8F-4600-81F3-E4105B691FDA</gtr:id><gtr:title>Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2918f0e3820429f15952099f7448aa4"><gtr:id>f2918f0e3820429f15952099f7448aa4</gtr:id><gtr:otherNames>Le Doare K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>5a9eed075d0558.74217992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D54ABD8A-1E5D-4DBA-8DCA-6BD623308AFE</gtr:id><gtr:title>Evolution of atypical enteropathogenic E. coli by repeated acquisition of LEE pathogenicity island variants.</gtr:title><gtr:parentPublicationTitle>Nature microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f01b5e0109378af8c562aab75c61472"><gtr:id>2f01b5e0109378af8c562aab75c61472</gtr:id><gtr:otherNames>Ingle DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2058-5276</gtr:issn><gtr:outcomeId>58c98bb672dfb0.50939406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63342BED-E321-4C6A-8A0C-2CB8E1117ADE</gtr:id><gtr:title>Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbd9cb794d60ad6017c8b7d55cbd8f5d"><gtr:id>bbd9cb794d60ad6017c8b7d55cbd8f5d</gtr:id><gtr:otherNames>Ota MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>P1WGHB2t6pj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B635FA71-8A3A-4D51-9057-CCBDB5BD8016</gtr:id><gtr:title>Salmonella Infections in The Gambia, 2005-2015.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb6e9d0c984ddf71b44ca96330dafa46"><gtr:id>bb6e9d0c984ddf71b44ca96330dafa46</gtr:id><gtr:otherNames>Kwambana-Adams B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>56cf4a45e73669.82362170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A759CEAC-DE2A-4AEA-A9D3-1BC6F72B6FE2</gtr:id><gtr:title>Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa.</gtr:title><gtr:parentPublicationTitle>Clinical biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31280647f7f04f7868b4ebe948769d88"><gtr:id>31280647f7f04f7868b4ebe948769d88</gtr:id><gtr:otherNames>Corstjens PL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0009-9120</gtr:issn><gtr:outcomeId>5641c8b77253a8.67747336</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B784895-84C1-4530-8217-63BE63B881FA</gtr:id><gtr:title>Comparison of TB-LAMP, GeneXpert MTB/RIF and culture for diagnosis of pulmonary tuberculosis in The Gambia.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c13d5c3426d3d9cf62b9a40f941977f6"><gtr:id>c13d5c3426d3d9cf62b9a40f941977f6</gtr:id><gtr:otherNames>Bojang AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>56bda84a60f9a8.17742393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6DCA99B-9C15-4CD1-BBC2-96A7DDCA780C</gtr:id><gtr:title>The Burden of Cryptosporidium Diarrheal Disease among Children &amp;lt; 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS).</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/317ffab8917651d353229d531040fd5a"><gtr:id>317ffab8917651d353229d531040fd5a</gtr:id><gtr:otherNames>Sow SO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>58c98bb7a417c1.70282386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D78A2FC2-C8B3-48A1-A73C-A89C49BD4639</gtr:id><gtr:title>Highly accurate diagnosis of pleural tuberculosis by immunological analysis of the pleural effusion.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c721e059d2551533a2a9aa5e0ffde77b"><gtr:id>c721e059d2551533a2a9aa5e0ffde77b</gtr:id><gtr:otherNames>Sutherland JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_23588_28_22295081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1833D9F8-834D-4F90-B188-DD9AA3E84EC5</gtr:id><gtr:title>Association of slow recovery of Mycobacterium africanum-infected patients posttreatment with high content of Persister-Like bacilli in pretreatment sputum.</gtr:title><gtr:parentPublicationTitle>International journal of mycobacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2ecf50e86c7e8e51297ab5a17dc502c"><gtr:id>f2ecf50e86c7e8e51297ab5a17dc502c</gtr:id><gtr:otherNames>Tientcheu LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2212-5531</gtr:issn><gtr:outcomeId>58aee16cc37165.17293864</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63C152B4-0029-41BF-923A-36AF1276B7C3</gtr:id><gtr:title>Elevated serum 25-hydroxy (OH) vitamin D levels are associated with risk of TB progression in Gambian adults.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2438d434fe9a12d3adf0b3701db5a391"><gtr:id>2438d434fe9a12d3adf0b3701db5a391</gtr:id><gtr:otherNames>Owolabi O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>58aee16d29f205.87671256</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBDCCD1E-9FD9-4043-9BD3-0EC6C230C313</gtr:id><gtr:title>Genomic diversity of EPEC associated with clinical presentations of differing severity.</gtr:title><gtr:parentPublicationTitle>Nature microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/354466fe25c7291d4aaa88cac0a75d23"><gtr:id>354466fe25c7291d4aaa88cac0a75d23</gtr:id><gtr:otherNames>Hazen TH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2058-5276</gtr:issn><gtr:outcomeId>58c98bb4a76bf6.99723999</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8719A19-E24F-4311-8901-F788944AEE40</gtr:id><gtr:title>The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8fa3e311c4f6e1e8f3a5e0ddf1c1d88"><gtr:id>a8fa3e311c4f6e1e8f3a5e0ddf1c1d88</gtr:id><gtr:otherNames>Dodd PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>58b0a999cc31a5.95382480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13ADF75A-4B69-42B7-A35F-D1D10B830976</gtr:id><gtr:title>Placental transfer of anti-group B Streptococcus immunoglobulin G antibody subclasses from HIV-infected and uninfected women to their uninfected infants.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2918f0e3820429f15952099f7448aa4"><gtr:id>f2918f0e3820429f15952099f7448aa4</gtr:id><gtr:otherNames>Le Doare K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>58b0b54f2ea2c1.54013281</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC234AD9-F73F-49EE-829F-4A82752EA868</gtr:id><gtr:title>Macrophage Exosomes Induce Placental Inflammatory Cytokines: A Novel Mode of Maternal-Placental Messaging.</gtr:title><gtr:parentPublicationTitle>Traffic (Copenhagen, Denmark)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd5ee062a6030ab11cb7eb3bb7520717"><gtr:id>dd5ee062a6030ab11cb7eb3bb7520717</gtr:id><gtr:otherNames>Holder B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1398-9219</gtr:issn><gtr:outcomeId>58b0b54f88c7e1.69220253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62341445-D28C-418C-8A71-410C1EEA001D</gtr:id><gtr:title>Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8630d38a88c3f539cee58b8275068ee2"><gtr:id>8630d38a88c3f539cee58b8275068ee2</gtr:id><gtr:otherNames>Idoko OT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5a9eed079952c5.38293798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F983ABF7-56E6-4468-A9BA-334EB221E565</gtr:id><gtr:title>Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f036122586408ab58e9c6f0fed49a4c4"><gtr:id>f036122586408ab58e9c6f0fed49a4c4</gtr:id><gtr:otherNames>Barger-Kamate B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>58c94bd3ce7505.27899279</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C029BB64-99D9-4394-BA89-FEA84A4CF115</gtr:id><gtr:title>Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5149d219d7240db05041302902c6636"><gtr:id>b5149d219d7240db05041302902c6636</gtr:id><gtr:otherNames>Lange C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>545bcfec3da585.49325604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13A965A7-AB9B-4224-843C-6F6778EA0BB9</gtr:id><gtr:title>Multidrug-resistant tuberculosis in UK children: presentation, management and outcome.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d89e58fb4243e402c0edd05290c44155"><gtr:id>d89e58fb4243e402c0edd05290c44155</gtr:id><gtr:otherNames>Williams B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pm_13512_22_23728407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F739B26E-45ED-442D-BF0F-C36774DA11D0</gtr:id><gtr:title>Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d7533d199dc05be90709dffd1cf0467"><gtr:id>6d7533d199dc05be90709dffd1cf0467</gtr:id><gtr:otherNames>Parker EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>545bcfebe57f41.92872170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>982DBD0E-024D-4367-9E87-4BEB371ECA48</gtr:id><gtr:title>A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfade195e59376993f5bd5e519fb6b4c"><gtr:id>cfade195e59376993f5bd5e519fb6b4c</gtr:id><gtr:otherNames>Odutola AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>pm_15841_21_22749600</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79341147-A1F1-4327-BDB9-57FA748747A1</gtr:id><gtr:title>Preventive chemotherapy for contacts of MDR-TB: is the proof in the pudding?</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5149d219d7240db05041302902c6636"><gtr:id>b5149d219d7240db05041302902c6636</gtr:id><gtr:otherNames>Lange C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>545bcf9a652e73.33593469</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57FE4842-1D35-4792-89C3-DE20602F0D59</gtr:id><gtr:title>Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0bc40c6a9f6f58728d5dd08cadcb30f"><gtr:id>f0bc40c6a9f6f58728d5dd08cadcb30f</gtr:id><gtr:otherNames>Mensah VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a9eed0489c953.10815142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB7BEF2C-A4FD-418E-AD41-BB7FBA1C4F4C</gtr:id><gtr:title>SIgA, TGF-?1, IL-10, and TNFa in Colostrum Are Associated with Infant Group BColonization.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2918f0e3820429f15952099f7448aa4"><gtr:id>f2918f0e3820429f15952099f7448aa4</gtr:id><gtr:otherNames>Le Doare K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a9eed052d1142.34518568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD0D9AC5-D7D1-430A-AE0F-2DA4304D3C63</gtr:id><gtr:title>A functional whole blood assay to measure viability of mycobacteria, using reporter-gene tagged BCG or M.Tb (BCGlux/M.Tb lux).</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb7a8755ae67c1e3789af93f5c04ed2b"><gtr:id>fb7a8755ae67c1e3789af93f5c04ed2b</gtr:id><gtr:otherNames>Newton S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn><gtr:outcomeId>pm_13512_22_21946922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A4827D8-9171-4832-8CFE-3230FE046038</gtr:id><gtr:title>Childhood tuberculosis: progress requires an advocacy strategy now.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e482e69167b47df6d10f3fffb4a308a"><gtr:id>7e482e69167b47df6d10f3fffb4a308a</gtr:id><gtr:otherNames>Sandgren A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pm_13512_22_22337859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>634C9F54-F900-4D46-90B4-D71ABC4D9F40</gtr:id><gtr:title>Achieving comprehensive childhood immunization: an analysis of obstacles and opportunities in The Gambia.</gtr:title><gtr:parentPublicationTitle>Health policy and planning</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc044d54aab02647920c01b68ec09a5d"><gtr:id>bc044d54aab02647920c01b68ec09a5d</gtr:id><gtr:otherNames>Payne S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0268-1080</gtr:issn><gtr:outcomeId>pm_13512_22_23426974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0B8871E-05BD-43D5-A91C-D8F434BADE60</gtr:id><gtr:title>Interferon-? ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54e75f29ffc79c9257e04566c7c6017c"><gtr:id>54e75f29ffc79c9257e04566c7c6017c</gtr:id><gtr:otherNames>Adetifa IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_23588_28_23220919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E51A4D95-EF3B-45B2-BBBC-DCF5DDEA6386</gtr:id><gtr:title>The impact of childhood vaccines on bacterial carriage in the nasopharynx: a longitudinal study.</gtr:title><gtr:parentPublicationTitle>Emerging themes in epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/789a421d44fb12ab4f55d9e4e5efddd0"><gtr:id>789a421d44fb12ab4f55d9e4e5efddd0</gtr:id><gtr:otherNames>Bottomley C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1742-7622</gtr:issn><gtr:outcomeId>56cf4a9f108364.17243007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C3A8CA0-D367-46B6-B67F-1647B9815E81</gtr:id><gtr:title>Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fc72bcbd5fd8bf785fad7b006ebc768"><gtr:id>1fc72bcbd5fd8bf785fad7b006ebc768</gtr:id><gtr:otherNames>Heath PT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>5a9eed05e67c04.56396519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB9BB88B-B9E2-4A54-87F2-EFB2355F8F7D</gtr:id><gtr:title>Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/242b3836ccf09f5018352f691c3cf3bd"><gtr:id>242b3836ccf09f5018352f691c3cf3bd</gtr:id><gtr:otherNames>Liu J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>58c98bb474e555.91663896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AE9FC02-E44C-40BB-ACE0-F7F706EFBB89</gtr:id><gtr:title>Short course treatment for MDR TB: jumping the gun?</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c159370750a8c30de0c07f31162d2e5"><gtr:id>4c159370750a8c30de0c07f31162d2e5</gtr:id><gtr:otherNames>Turkova A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5a9eed071e92b6.75413598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C2A2816-8143-4066-B1A6-99D682B638AF</gtr:id><gtr:title>Soluble ecto-5'-nucleotidase (5'-NT), alkaline phosphatase, and adenosine deaminase (ADA1) activities in neonatal blood favor elevated extracellular adenosine.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5ecadab198d28340237929f3d7ba6e1"><gtr:id>c5ecadab198d28340237929f3d7ba6e1</gtr:id><gtr:otherNames>Pettengill M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_13512_22_23897810</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>708897F2-017E-4BEE-9B6F-2110BB19812D</gtr:id><gtr:title>Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants.</gtr:title><gtr:parentPublicationTitle>Current opinion in infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16f14cd8f026aea2ff7349b5f4f9a0f9"><gtr:id>16f14cd8f026aea2ff7349b5f4f9a0f9</gtr:id><gtr:otherNames>Lindsey B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0951-7375</gtr:issn><gtr:outcomeId>pm_13512_22_23507974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EAF572F-F744-420C-AC1C-E7EDD07830A4</gtr:id><gtr:title>TBNET - Collaborative research on tuberculosis in Europe.</gtr:title><gtr:parentPublicationTitle>European journal of microbiology &amp; immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f038fe2b8108f91380ce4d7570ba2274"><gtr:id>f038fe2b8108f91380ce4d7570ba2274</gtr:id><gtr:otherNames>Giehl C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2062-509X</gtr:issn><gtr:outcomeId>545bd097eb28f5.52146508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDF88BCE-E0CC-4576-8541-728061012F5F</gtr:id><gtr:title>Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c8db3cd46020bb955dc93a9ad2d63f5"><gtr:id>6c8db3cd46020bb955dc93a9ad2d63f5</gtr:id><gtr:otherNames>Bliss CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>58b0ad632d2fe1.85047048</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78208DC1-98D8-4222-8AC7-62B9B65F32EC</gtr:id><gtr:title>Morbidity and Mortality Due to Bordetella pertussis: A Significant Pathogen in West Africa?</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cda45a6a26a4e43dac5e1b063bbf789a"><gtr:id>cda45a6a26a4e43dac5e1b063bbf789a</gtr:id><gtr:otherNames>Kampmann B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>58b0b54c431365.11118298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>889CAA3D-F528-4AC5-B6C7-A551E1D1F182</gtr:id><gtr:title>Aeromonas-Associated Diarrhea in Children Under 5 Years: The GEMS Experience.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09e502d4d2b957ba09f3aa5c63d7fdbe"><gtr:id>09e502d4d2b957ba09f3aa5c63d7fdbe</gtr:id><gtr:otherNames>Qamar FN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn><gtr:outcomeId>58c98bb6ca98c5.55900646</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83C5E320-F6B2-497C-B6D8-77C0388CAB7F</gtr:id><gtr:title>C-reactive protein, Neopterin and Beta2 microglobulin levels pre and post TB treatment in The Gambia.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30e0bc3277b90bda00da8287924ac5db"><gtr:id>30e0bc3277b90bda00da8287924ac5db</gtr:id><gtr:otherNames>Mendy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>58aee1c4975241.48139003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE59F29E-0A20-4E43-B68A-7C16B9A9D10A</gtr:id><gtr:title>Pneumococcal antibody concentrations of subjects in communities fully or partially vaccinated with a seven-valent pneumococcal conjugate vaccine.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbd9cb794d60ad6017c8b7d55cbd8f5d"><gtr:id>bbd9cb794d60ad6017c8b7d55cbd8f5d</gtr:id><gtr:otherNames>Ota MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15841_21_22916192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>347B031E-9BB9-4EF6-9E39-E184FF22C653</gtr:id><gtr:title>The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2765a26bdd37caa8fbd71943ba6d74a8"><gtr:id>2765a26bdd37caa8fbd71943ba6d74a8</gtr:id><gtr:otherNames>Gehre F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>58b0a99a7398f5.03259478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCF72B76-B992-4E32-8F68-4D8F334E9248</gtr:id><gtr:title>Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ec21bd2f573a922be2e247d9f4cff89"><gtr:id>7ec21bd2f573a922be2e247d9f4cff89</gtr:id><gtr:otherNames>Akinsola AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15841_21_22363544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27492A94-FE9D-48C9-B0C5-15D2C35DB3F6</gtr:id><gtr:title>Antimicrobial Proteins and Peptides in Early Life: Ontogeny and Translational Opportunities.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f52e5e0c9f11fd5dd2b330505c314eb"><gtr:id>2f52e5e0c9f11fd5dd2b330505c314eb</gtr:id><gtr:otherNames>Battersby AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>58b0b54cb25af9.30789993</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B221F3BE-B17A-4DF2-9FEB-0B88D6DE1C2F</gtr:id><gtr:title>Iron homeostasis and progression to pulmonary tuberculosis disease among household contacts.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/109444a10d09e9ed58baf403ba7c3ac8"><gtr:id>109444a10d09e9ed58baf403ba7c3ac8</gtr:id><gtr:otherNames>Minchella PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>5641c8b6cdc804.28462618</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D22A61D-8B51-4E55-ADE2-2CBE4DE282AC</gtr:id><gtr:title>Isoniazid preventive treatment among child contacts of adults with smear-positive tuberculosis in The Gambia.</gtr:title><gtr:parentPublicationTitle>Public health action</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/647342215b81b4d4dcd4d8a5b67db65a"><gtr:id>647342215b81b4d4dcd4d8a5b67db65a</gtr:id><gtr:otherNames>Egere U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2220-8372</gtr:issn><gtr:outcomeId>58b0a999a12bd8.88708945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CAF88FD-38C0-4BC5-AB0B-305A4AB50AFB</gtr:id><gtr:title>Role of human milk oligosaccharides in Group B Streptococcus colonisation.</gtr:title><gtr:parentPublicationTitle>Clinical &amp; translational immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ca7a078b4d2465cf187b1ce7015d883"><gtr:id>4ca7a078b4d2465cf187b1ce7015d883</gtr:id><gtr:otherNames>Andreas NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-0068</gtr:issn><gtr:outcomeId>58b0b54c8bb409.76036380</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31F53AD9-70A0-4902-B6F9-49D7AEF4C4B5</gtr:id><gtr:title>Face mask sampling for the detection of Mycobacterium tuberculosis in expelled aerosols.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c06d92173eb1564a7391e886577f4cf"><gtr:id>4c06d92173eb1564a7391e886577f4cf</gtr:id><gtr:otherNames>Williams CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545f76a4e2ee65.77365753</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8140B49F-F678-4A9B-88CB-E330C60018BC</gtr:id><gtr:title>What determines uptake of pertussis vaccine in pregnancy? A cross sectional survey in an ethnically diverse population of pregnant women in London.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c60cf4464ca6d927f8455ce0d2d5a240"><gtr:id>c60cf4464ca6d927f8455ce0d2d5a240</gtr:id><gtr:otherNames>Donaldson B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>56cf4a45023153.68878350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7697BE00-91C7-48D0-845F-3E46B00F3C6E</gtr:id><gtr:title>A multimedia consent tool for research participants in the Gambia: a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>Bulletin of the World Health Organization</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bd0b08c7569d3fbb892d3070c540098"><gtr:id>5bd0b08c7569d3fbb892d3070c540098</gtr:id><gtr:otherNames>Afolabi MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0042-9686</gtr:issn><gtr:outcomeId>56cf4a9b572c64.59953225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59BE2611-882F-4B11-9FFB-BD2B18163CF5</gtr:id><gtr:title>The genome of Mycobacterium africanum West African 2 reveals a lineage-specific locus and genome erosion common to the M. tuberculosis complex.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed467b9b110c9f187ed7663f41ed5a07"><gtr:id>ed467b9b110c9f187ed7663f41ed5a07</gtr:id><gtr:otherNames>Bentley SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>pm_23588_28_22389744</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>375BBB9A-855A-49D0-BE2E-0879BCCD0D10</gtr:id><gtr:title>Immune oxysterols: Role in mycobacterial infection and inflammation.</gtr:title><gtr:parentPublicationTitle>The Journal of steroid biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3816ad8792b42d8ca116f2ec9763882f"><gtr:id>3816ad8792b42d8ca116f2ec9763882f</gtr:id><gtr:otherNames>Bah SY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0960-0760</gtr:issn><gtr:outcomeId>58b0a99b050887.26182475</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0FB085D-DD58-479E-826E-458AF5FAEF50</gtr:id><gtr:title>The relationship between concentration of specific antibody at birth and subsequent response to primary immunization.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb717bce2e3d9f5f8e2e0fd9de5431d0"><gtr:id>eb717bce2e3d9f5f8e2e0fd9de5431d0</gtr:id><gtr:otherNames>Jones C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>545bd097c27bc3.52261711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40356B10-C613-414B-8045-B9255BEC8C7C</gtr:id><gtr:title>Identification of probable early-onset biomarkers for tuberculosis disease progression.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c721e059d2551533a2a9aa5e0ffde77b"><gtr:id>c721e059d2551533a2a9aa5e0ffde77b</gtr:id><gtr:otherNames>Sutherland JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_23588_28_21966464</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AC3D081-4187-4FBC-89CD-AF454458B87C</gtr:id><gtr:title>Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8630d38a88c3f539cee58b8275068ee2"><gtr:id>8630d38a88c3f539cee58b8275068ee2</gtr:id><gtr:otherNames>Idoko OT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>545f6c3e853907.09017087</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A65AB0B-0E9A-4876-98FB-FB43196C9723</gtr:id><gtr:title>Maternal and neonatal pneumococcal vaccination - where are we now?</gtr:title><gtr:parentPublicationTitle>Expert review of vaccines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d427600d7a231127ff9995f95c66a3e"><gtr:id>1d427600d7a231127ff9995f95c66a3e</gtr:id><gtr:otherNames>Clarke E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1476-0584</gtr:issn><gtr:outcomeId>58b0b54eda9cc9.86615063</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C3769FB-6168-4F11-BD95-D87FA7308506</gtr:id><gtr:title>Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bdffc049adbcb99401d65c52e5ff669"><gtr:id>3bdffc049adbcb99401d65c52e5ff669</gtr:id><gtr:otherNames>Jones CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>pm_13512_22_21304083</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45E660ED-D809-45C1-84FA-7493B042F23C</gtr:id><gtr:title>Skewing of the CD4(+) T-cell pool toward monofunctional antigen-specific responses in patients with immune reconstitution inflammatory syndrome in The Gambia.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9c8402918ea8e3bd47a06f8f7680221"><gtr:id>e9c8402918ea8e3bd47a06f8f7680221</gtr:id><gtr:otherNames>Wilson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>pm_23588_28_23645847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03926BEC-9265-45A2-B9CC-E70EEA898B92</gtr:id><gtr:title>Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputum.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbd9cb794d60ad6017c8b7d55cbd8f5d"><gtr:id>bbd9cb794d60ad6017c8b7d55cbd8f5d</gtr:id><gtr:otherNames>Ota MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>545bcfec63b365.13574982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEDB4C36-784C-4E61-B305-9B92EFD2DC91</gtr:id><gtr:title>Factors affecting immunogenicity of BCG in infants, a study in Malawi, The Gambia and the UK.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3327b507198c215ad56f639173d2269d"><gtr:id>3327b507198c215ad56f639173d2269d</gtr:id><gtr:otherNames>Hur YG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>545f6c3e0ab438.72155400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E6FFE25-4C31-4011-A3B7-EA4F59A8E9B5</gtr:id><gtr:title>Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80e8b533eb8d95dfc5774b593f2b5244"><gtr:id>80e8b533eb8d95dfc5774b593f2b5244</gtr:id><gtr:otherNames>Joosten SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>pm_23588_28_21956656</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D75C4C91-AE48-481F-9900-D418CB3FCB72</gtr:id><gtr:title>Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66a5780653887989616b1c6ad11d85bc"><gtr:id>66a5780653887989616b1c6ad11d85bc</gtr:id><gtr:otherNames>Burl S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13512_22_21533209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37D5B107-217E-4C78-9E4F-71ACB43C8C19</gtr:id><gtr:title>Immunization status of children with HIV: failure to protect a vulnerable population.</gtr:title><gtr:parentPublicationTitle>HIV medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1247f44d77e0dac0d582bf988fd90e36"><gtr:id>1247f44d77e0dac0d582bf988fd90e36</gtr:id><gtr:otherNames>Zinna S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1464-2662</gtr:issn><gtr:outcomeId>pm_13512_22_21729230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>313CE5F0-55B0-473F-9890-1152456DFC0B</gtr:id><gtr:title>Meeting report: The International Conference on Human Immunity to Tuberculosis.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51213e1439f79e24d625fac61114001f"><gtr:id>51213e1439f79e24d625fac61114001f</gtr:id><gtr:otherNames>Ernst JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>pm_13512_22_22658910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DAEADC2-F2C3-4713-911E-AE3BBA329C92</gtr:id><gtr:title>Incidence of macrolide-lincosamide-streptogramin B resistance amongst beta-haemolytic streptococci in The Gambia.</gtr:title><gtr:parentPublicationTitle>BMC research notes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6ef0759dc8a0d2f9e7e260ed349f798"><gtr:id>e6ef0759dc8a0d2f9e7e260ed349f798</gtr:id><gtr:otherNames>Foster-Nyarko E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1756-0500</gtr:issn><gtr:outcomeId>58c98ade537ad7.72395032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C7EE5DF-06DD-4F51-87B7-CEB9B2175D62</gtr:id><gtr:title>MCP1 SNPs and pulmonary tuberculosis in cohorts from West Africa, the USA and Argentina: lack of association or epistasis with IL12B polymorphisms.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7f33a6f489be7d124d660dda3fef518"><gtr:id>d7f33a6f489be7d124d660dda3fef518</gtr:id><gtr:otherNames>Velez Edwards DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_23588_28_22384203</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D87FAE62-D83E-46E9-BC9A-EFB3AA603707</gtr:id><gtr:title>Interleukin 12B (IL12B) genetic variation and pulmonary tuberculosis: a study of cohorts from The Gambia, Guinea-Bissau, United States and Argentina.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2478fd36f580f88bf4f18d95bd685df3"><gtr:id>2478fd36f580f88bf4f18d95bd685df3</gtr:id><gtr:otherNames>Morris GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_23588_28_21339808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>693FD740-6720-45C7-9C09-55DB0FBAD5B6</gtr:id><gtr:title>Community Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8630d38a88c3f539cee58b8275068ee2"><gtr:id>8630d38a88c3f539cee58b8275068ee2</gtr:id><gtr:otherNames>Idoko OT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>56cf4a45ae80b2.33967162</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F7ABD00-C3AC-4E61-8003-151184B09648</gtr:id><gtr:title>Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An Update.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/914a5d9d73e66a78a254c31b21274506"><gtr:id>914a5d9d73e66a78a254c31b21274506</gtr:id><gtr:otherNames>Graham SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>56cf4a9a225c51.62551612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFA228C0-5C88-4A63-862E-C884F5C33661</gtr:id><gtr:title>Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d427600d7a231127ff9995f95c66a3e"><gtr:id>1d427600d7a231127ff9995f95c66a3e</gtr:id><gtr:otherNames>Clarke E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>58b0b54d8efdc6.22990660</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE6741D6-0F66-4F80-BC9E-ED8ADEC2EDA5</gtr:id><gtr:title>Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/284cd12a17b1f1eb64635b20cf4c4168"><gtr:id>284cd12a17b1f1eb64635b20cf4c4168</gtr:id><gtr:otherNames>Vergnano S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>58b0b54d683bd3.30596088</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8925FB4E-1325-427B-AFA4-7B7CD7E3120C</gtr:id><gtr:title>HIV and tuberculosis in children: biology meets epidemiology.</gtr:title><gtr:parentPublicationTitle>The lancet. HIV</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff0ce7c349f66f838975792025ead9f1"><gtr:id>ff0ce7c349f66f838975792025ead9f1</gtr:id><gtr:otherNames>Seddon JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2352-3018</gtr:issn><gtr:outcomeId>56cf4a442ca0d9.12249021</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3295B27-F125-4AA4-84AF-60530D5DE946</gtr:id><gtr:title>Changes in Host Cytokine Patterns of TB Patients with Different Bacterial Loads Detected Using 16S rRNA Analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb9da33984e91d417cfb6e083548480c"><gtr:id>bb9da33984e91d417cfb6e083548480c</gtr:id><gtr:otherNames>Heslop R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58aee1c40a0d54.13509034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA14FAE8-BB9E-4910-B3ED-8272048064C6</gtr:id><gtr:title>Human breast milk: A review on its composition and bioactivity.</gtr:title><gtr:parentPublicationTitle>Early human development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ca7a078b4d2465cf187b1ce7015d883"><gtr:id>4ca7a078b4d2465cf187b1ce7015d883</gtr:id><gtr:otherNames>Andreas NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0378-3782</gtr:issn><gtr:outcomeId>56cf4a44c3f601.40458364</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9AC9C15-B65E-435D-94F4-9FE0129E7025</gtr:id><gtr:title>Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2918f0e3820429f15952099f7448aa4"><gtr:id>f2918f0e3820429f15952099f7448aa4</gtr:id><gtr:otherNames>Le Doare K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5a9eed062edd02.05215468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E11C8ED5-6CF8-459D-A5CE-0205B3DC5674</gtr:id><gtr:title>Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9b1d85c688f62ea6f8460ca59dd9d92"><gtr:id>a9b1d85c688f62ea6f8460ca59dd9d92</gtr:id><gtr:otherNames>Armitage EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5aaa3c289d4c66.98973843</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14CC80FC-5A4F-462B-A369-7700638A7841</gtr:id><gtr:title>Vitamin D in early childhood and the effect on immunity to Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Clinical &amp; developmental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f52e5e0c9f11fd5dd2b330505c314eb"><gtr:id>2f52e5e0c9f11fd5dd2b330505c314eb</gtr:id><gtr:otherNames>Battersby AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1740-2522</gtr:issn><gtr:outcomeId>pm_13512_22_22829851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0BEB21C-4219-4898-8D9D-B227BF62432E</gtr:id><gtr:title>Vaccine responses in newborns.</gtr:title><gtr:parentPublicationTitle>Seminars in immunopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a92b5cd94d776add338efc8f084ebe55"><gtr:id>a92b5cd94d776add338efc8f084ebe55</gtr:id><gtr:otherNames>Saso A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1863-2297</gtr:issn><gtr:outcomeId>5a2fda63e551d1.34311732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>492D6035-BBE5-4282-8748-D3C0060F403A</gtr:id><gtr:title>Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ea9b9a2464d712e60c03cad0a454817"><gtr:id>8ea9b9a2464d712e60c03cad0a454817</gtr:id><gtr:otherNames>Chegou NN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>58aee16cf237d2.71245581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40B3D934-68A6-42E2-B839-14B7BDC755BD</gtr:id><gtr:title>Lessons in participant retention in the course of a randomized controlled clinical trial.</gtr:title><gtr:parentPublicationTitle>BMC research notes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8630d38a88c3f539cee58b8275068ee2"><gtr:id>8630d38a88c3f539cee58b8275068ee2</gtr:id><gtr:otherNames>Idoko OT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1756-0500</gtr:issn><gtr:outcomeId>545f6c3e5e8204.19759746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A191D03-D857-4FE2-B17A-50887365E6D4</gtr:id><gtr:title>Kawasaki disease coincident with influenza A H1N1/09 infection.</gtr:title><gtr:parentPublicationTitle>Pediatrics international : official journal of the Japan Pediatric Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ddadd1b4b6779f9d60fe5bd7514a124"><gtr:id>8ddadd1b4b6779f9d60fe5bd7514a124</gtr:id><gtr:otherNames>Joshi AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1328-8067</gtr:issn><gtr:outcomeId>pm_13512_22_21342333</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCE31DB1-188D-42D5-8134-0B7B81F26744</gtr:id><gtr:title>One size fits all? Antibody avidity measurement against multiple antigens in maternal vaccination studies.</gtr:title><gtr:parentPublicationTitle>Virulence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a70623d2179c1b845e5da668c399494"><gtr:id>6a70623d2179c1b845e5da668c399494</gtr:id><gtr:otherNames>Rice T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2150-5594</gtr:issn><gtr:outcomeId>5a9eed06dc3760.05998432</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>320FF845-21BD-4128-9014-3656436FB960</gtr:id><gtr:title>Bacterial Isolates and Antibiotic Sensitivity among Gambian Children with Severe Acute Malnutrition.</gtr:title><gtr:parentPublicationTitle>International journal of pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b991a05bb435b0d9b82486d5bf925bc6"><gtr:id>b991a05bb435b0d9b82486d5bf925bc6</gtr:id><gtr:otherNames>Okomo UA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1687-9740</gtr:issn><gtr:outcomeId>qifRKyR37bt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA063568-7A2A-435C-BC7F-169579F7A5C2</gtr:id><gtr:title>Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdbb119d400cb9526a9e82f78c4f9e2b"><gtr:id>cdbb119d400cb9526a9e82f78c4f9e2b</gtr:id><gtr:otherNames>Renna M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>pm_13512_22_21804191</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EC0A6CC-664E-42BF-A9A5-EE24ECAFA314</gtr:id><gtr:title>Risk factors for Group B Streptococcus colonisation and disease in Gambian women and their infants.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2918f0e3820429f15952099f7448aa4"><gtr:id>f2918f0e3820429f15952099f7448aa4</gtr:id><gtr:otherNames>Le Doare K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>58b0b54f0d02b2.07209783</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8466B48-167C-41D6-9E22-52EE83A9450E</gtr:id><gtr:title>The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/653f10e4ccc9a9f1b5cec367ef12894b"><gtr:id>653f10e4ccc9a9f1b5cec367ef12894b</gtr:id><gtr:otherNames>Bumbacea D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pm_13512_22_22496318</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9F6E819-885D-4AB0-849A-E815D7DC229C</gtr:id><gtr:title>Oral azithromycin given during labour decreases bacterial carriage in the mothers and their offspring: a double-blind randomized trial.</gtr:title><gtr:parentPublicationTitle>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0361db51415d8d4cce9e2fb002a631ad"><gtr:id>0361db51415d8d4cce9e2fb002a631ad</gtr:id><gtr:otherNames>Roca A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1198-743X</gtr:issn><gtr:outcomeId>58b0b54eafc912.48567362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACB42937-00AC-4937-B02E-46616C3B1B53</gtr:id><gtr:title>The Immunogenicity of Fractional Intradermal Doses of the Inactivated Poliovirus Vaccine Is Associated With the Size of the Intradermal Fluid Bleb.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bc02dfd10b5ed3768377a6628c07e55"><gtr:id>3bc02dfd10b5ed3768377a6628c07e55</gtr:id><gtr:otherNames>Bibby J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>5a9eed08ce75b1.81051085</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4512E852-1A76-4542-BA24-5B9D0FB09A00</gtr:id><gtr:title>Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/369bb73cc7f56116e9875ea77b3da19c"><gtr:id>369bb73cc7f56116e9875ea77b3da19c</gtr:id><gtr:otherNames>Tapia MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>56cf4a4573c051.20743477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8065B4D9-447D-4986-8103-6B5B25D692D1</gtr:id><gtr:title>Increased disease due to Haemophilus influenzae type b: population-based surveillance in eastern Gambia, 2008-2013.</gtr:title><gtr:parentPublicationTitle>The Pediatric infectious disease journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91ed8fbc4f7229b333b42393e35226ed"><gtr:id>91ed8fbc4f7229b333b42393e35226ed</gtr:id><gtr:otherNames>Mackenzie GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0891-3668</gtr:issn><gtr:outcomeId>56cf4a9ca76026.07722478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BB866AE-A76E-4D07-98B2-4327DA2E4241</gtr:id><gtr:title>Biological challenges to effective vaccines in the developing world.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad477705d4c8966434296d200f476ba2"><gtr:id>ad477705d4c8966434296d200f476ba2</gtr:id><gtr:otherNames>Grassly NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>56cf4a9bb3f289.90944936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88B360F2-9698-4F6E-AD98-C302602B80EE</gtr:id><gtr:title>Alternative Molecular Methods for Improved Detection of Meningococcal Carriage and Measurement of Bacterial Density.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25705fc4d920fc7aeb512c833db218ac"><gtr:id>25705fc4d920fc7aeb512c833db218ac</gtr:id><gtr:otherNames>Manigart O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>58b0b54d0f0668.51798106</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D6391B8-E1D9-4924-A48A-9258E8712EF4</gtr:id><gtr:title>Broad adaptive immune responses to M. tuberculosis antigens precede TST conversion in tuberculosis exposed household contacts in a TB-endemic setting.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78ff61a1d89783ad0c374d1276061097"><gtr:id>78ff61a1d89783ad0c374d1276061097</gtr:id><gtr:otherNames>Buchwald UK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5641c8b6a554d4.37512646</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74DD7EBF-D693-40AA-A9A1-B4CC3DA9843B</gtr:id><gtr:title>A blood RNA signature for tuberculosis disease risk: a prospective cohort study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f702a7e4ae9fb3946fa30a8cceb009e"><gtr:id>2f702a7e4ae9fb3946fa30a8cceb009e</gtr:id><gtr:otherNames>Zak DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>58aee32da09f76.00591545</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E8F8CC1-9900-4821-9E57-781F3C62D76C</gtr:id><gtr:title>Toxicity and tolerability of fluoroquinolone-based preventive therapy for childhood contacts of multidrug-resistant tuberculosis.</gtr:title><gtr:parentPublicationTitle>The Pediatric infectious disease journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff0ce7c349f66f838975792025ead9f1"><gtr:id>ff0ce7c349f66f838975792025ead9f1</gtr:id><gtr:otherNames>Seddon JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0891-3668</gtr:issn><gtr:outcomeId>545bcf45cac997.42576787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78E72926-8421-4A84-AD5F-E148F26F607C</gtr:id><gtr:title>Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f39d7f0b5fe6b87ffc8ad45525bc4330"><gtr:id>f39d7f0b5fe6b87ffc8ad45525bc4330</gtr:id><gtr:otherNames>Diel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pm_13512_22_21030451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6248A0E-EB34-4108-85CF-D699B9E3629F</gtr:id><gtr:title>Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24f1223eef376650f6ccc70c7c1edc04"><gtr:id>24f1223eef376650f6ccc70c7c1edc04</gtr:id><gtr:otherNames>Kollmann TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>5a9eed092b74f2.61896016</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10B22149-ECE9-4B78-ABEA-1CE793DDCBB4</gtr:id><gtr:title>Seroprevalence of pertussis in the Gambia: evidence for continued circulation of bordetella pertussis despite high vaccination rates.</gtr:title><gtr:parentPublicationTitle>The Pediatric infectious disease journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41a1121db9f971503c2bd7f8fa4d4247"><gtr:id>41a1121db9f971503c2bd7f8fa4d4247</gtr:id><gtr:otherNames>Scott S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0891-3668</gtr:issn><gtr:outcomeId>56cf4a9d203547.98481274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30CE7CB4-F0BB-4DCF-8170-EE27E10007B2</gtr:id><gtr:title>Management of pediatric contacts of multidrug resistant tuberculosis in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>The Pediatric infectious disease journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d89e58fb4243e402c0edd05290c44155"><gtr:id>d89e58fb4243e402c0edd05290c44155</gtr:id><gtr:otherNames>Williams B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0891-3668</gtr:issn><gtr:outcomeId>pm_13512_22_23856715</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93E6194F-E05B-4695-829B-918096C3E466</gtr:id><gtr:title>Identifying children with tuberculosis among household contacts in The Gambia.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/647342215b81b4d4dcd4d8a5b67db65a"><gtr:id>647342215b81b4d4dcd4d8a5b67db65a</gtr:id><gtr:otherNames>Egere U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>58b0a9992e6688.51503252</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7790CE81-CA6E-4898-9E89-13A7B22CC65F</gtr:id><gtr:title>Recall and decay of consent information among parents of infants participating in a randomized controlled clinical trial using an audio-visual tool in The Gambia.</gtr:title><gtr:parentPublicationTitle>Human vaccines &amp; immunotherapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5524b4734d74f37f88be73e9c48e815"><gtr:id>a5524b4734d74f37f88be73e9c48e815</gtr:id><gtr:otherNames>Mboizi RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2164-5515</gtr:issn><gtr:outcomeId>5a9eed05a0c264.70670475</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2715F22E-19FC-41E6-9A63-FDBEC2F5D435</gtr:id><gtr:title>In reply.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/647342215b81b4d4dcd4d8a5b67db65a"><gtr:id>647342215b81b4d4dcd4d8a5b67db65a</gtr:id><gtr:otherNames>Egere U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>5a9eed084fa062.34650032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66381953-E281-4701-B796-EB42B5C66BFC</gtr:id><gtr:title>How to use: interferon ? release assays for tuberculosis.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Education and practice edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91890f7a1b667277c672c547c0673a1d"><gtr:id>91890f7a1b667277c672c547c0673a1d</gtr:id><gtr:otherNames>Pollock L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1743-0585</gtr:issn><gtr:outcomeId>pm_13512_22_23580543</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>198A881B-141D-4DBD-B0C5-12BAC357D11F</gtr:id><gtr:title>Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2104b231abdb8320285655018612a056"><gtr:id>2104b231abdb8320285655018612a056</gtr:id><gtr:otherNames>Tr?ck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5aaa3e039f2025.72540015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>719A04CF-CF5F-4E6F-B5C7-84E1A1C7F52D</gtr:id><gtr:title>Management of child MDR-TB contacts across countries in the WHO European Region: a survey of current practice.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c159370750a8c30de0c07f31162d2e5"><gtr:id>4c159370750a8c30de0c07f31162d2e5</gtr:id><gtr:otherNames>Turkova A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>5a9eed088a5a64.66359210</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88A9EAF4-2528-4C20-8992-2ADF15765D6A</gtr:id><gtr:title>Use of lateral flow assays to determine IP-10 and CCL4 levels in pleural effusions and whole blood for TB diagnosis.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c721e059d2551533a2a9aa5e0ffde77b"><gtr:id>c721e059d2551533a2a9aa5e0ffde77b</gtr:id><gtr:otherNames>Sutherland JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>58aee16d5d2a84.00726975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22E85D8A-2AC6-454F-81DB-DC10B3B0E240</gtr:id><gtr:title>Prescribing amoxicillin for babies up to 3 months of age: definitely time for change.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35e0ad7b104ac9200c5df43eb6e39b52"><gtr:id>35e0ad7b104ac9200c5df43eb6e39b52</gtr:id><gtr:otherNames>Malley M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>58b0b54f549835.75708998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F89960C-C04B-4071-BEEA-8F1F0790CC94</gtr:id><gtr:title>The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbd9cb794d60ad6017c8b7d55cbd8f5d"><gtr:id>bbd9cb794d60ad6017c8b7d55cbd8f5d</gtr:id><gtr:otherNames>Ota MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>mBQTBo7Y78U</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>352331B3-E444-43D6-959F-47D9D451ABCB</gtr:id><gtr:title>Ebola: a holistic approach is required to achieve effective management and control.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0361db51415d8d4cce9e2fb002a631ad"><gtr:id>0361db51415d8d4cce9e2fb002a631ad</gtr:id><gtr:otherNames>Roca A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56cf4a9cd6f400.37358736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D22630F6-1635-44C7-8C56-0FF3674F189B</gtr:id><gtr:title>Evaluation of the Kudoh method for mycobacterial culture: Gambia experience.</gtr:title><gtr:parentPublicationTitle>International journal of mycobacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/033ea41d1086e9d25678f8a0e70404d4"><gtr:id>033ea41d1086e9d25678f8a0e70404d4</gtr:id><gtr:otherNames>Jobarteh T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2212-5531</gtr:issn><gtr:outcomeId>58c98adeb797a7.44258462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63214EE1-A857-48E9-852F-380713B8C551</gtr:id><gtr:title>Immunological consequences of strain variation within the Mycobacterium tuberculosis complex.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2ecf50e86c7e8e51297ab5a17dc502c"><gtr:id>f2ecf50e86c7e8e51297ab5a17dc502c</gtr:id><gtr:otherNames>Tientcheu LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>58b0a9996e9f70.00743134</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>593F1E9C-152A-4ED6-AF30-5331A559BA69</gtr:id><gtr:title>Identifying predictors of interferon-? release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb1713935960ba4e6ada861507a76d09"><gtr:id>bb1713935960ba4e6ada861507a76d09</gtr:id><gtr:otherNames>Basu Roy R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_13512_22_22700862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A63FE99-03CC-4687-8E9D-6BE4B2E3645A</gtr:id><gtr:title>Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0361db51415d8d4cce9e2fb002a631ad"><gtr:id>0361db51415d8d4cce9e2fb002a631ad</gtr:id><gtr:otherNames>Roca A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>56cf4a4458e846.69718725</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A94F7E9-132A-40C1-B3D0-0D0305AD7675</gtr:id><gtr:title>Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a92b5cd94d776add338efc8f084ebe55"><gtr:id>a92b5cd94d776add338efc8f084ebe55</gtr:id><gtr:otherNames>Saso A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>58b0b54db69bc1.43143144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCC8BD93-D2B1-435E-B2C0-CFEB8D864803</gtr:id><gtr:title>An outbreak of pneumococcal meningitis among older children (=5&amp;nbsp;years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c321d78409ed6f6822fa72581eb5a17"><gtr:id>5c321d78409ed6f6822fa72581eb5a17</gtr:id><gtr:otherNames>Kwambana-Adams BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>58c94c5059fc75.67405528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA28A280-DFFA-4964-97EE-48D15091D48E</gtr:id><gtr:title>Monocyte unresponsiveness and impaired IL1?, TNFa and IL7 production are associated with a poor outcome in Malawian adults with pulmonary tuberculosis.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4d57e7ccac0cf1e7cbdb915c51fa748"><gtr:id>e4d57e7ccac0cf1e7cbdb915c51fa748</gtr:id><gtr:otherNames>Waitt CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>56cf4a9e8e32d1.89852719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>172007E4-B020-4DAF-B232-874B894436FC</gtr:id><gtr:title>Prevention of bacterial infections in the newborn by pre-delivery administration of azithromycin: Study protocol of a randomized efficacy trial.</gtr:title><gtr:parentPublicationTitle>BMC pregnancy and childbirth</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0361db51415d8d4cce9e2fb002a631ad"><gtr:id>0361db51415d8d4cce9e2fb002a631ad</gtr:id><gtr:otherNames>Roca A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2393</gtr:issn><gtr:outcomeId>56cf4a9ebc6b78.18410532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DCCB432-D7C1-49EC-8251-F9200AF84F08</gtr:id><gtr:title>Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2918f0e3820429f15952099f7448aa4"><gtr:id>f2918f0e3820429f15952099f7448aa4</gtr:id><gtr:otherNames>Le Doare K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5aaa3e03db89b9.44718794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD03A7BA-D087-4D19-AC7B-0E5AD68BD1C3</gtr:id><gtr:title>The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8630d38a88c3f539cee58b8275068ee2"><gtr:id>8630d38a88c3f539cee58b8275068ee2</gtr:id><gtr:otherNames>Idoko OT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>54564fe4a745c7.77138694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58160B86-39FA-4DE2-8B5E-82413EC56882</gtr:id><gtr:title>The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff0ce7c349f66f838975792025ead9f1"><gtr:id>ff0ce7c349f66f838975792025ead9f1</gtr:id><gtr:otherNames>Seddon JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>58b0a99a9e8f34.22848941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52A39A55-F961-4DB2-8D18-5F723E5060D6</gtr:id><gtr:title>Current understanding of the immune response to tuberculosis in children.</gtr:title><gtr:parentPublicationTitle>Current opinion in infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb1713935960ba4e6ada861507a76d09"><gtr:id>bb1713935960ba4e6ada861507a76d09</gtr:id><gtr:otherNames>Basu Roy R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0951-7375</gtr:issn><gtr:outcomeId>pm_13512_22_22491144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C187E90F-48BB-4331-8FA3-D89314CD3B26</gtr:id><gtr:title>Human immune responses to vaccines in the first year of life: biological, socio-economic and ethical issues - a viewpoint.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbd9cb794d60ad6017c8b7d55cbd8f5d"><gtr:id>bbd9cb794d60ad6017c8b7d55cbd8f5d</gtr:id><gtr:otherNames>Ota MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>pm_15841_21_22728219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A94755B-43D3-4D01-AF92-F7CDC86B7069</gtr:id><gtr:title>Differential gene expression of activating Fc? receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity.</gtr:title><gtr:parentPublicationTitle>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c721e059d2551533a2a9aa5e0ffde77b"><gtr:id>c721e059d2551533a2a9aa5e0ffde77b</gtr:id><gtr:otherNames>Sutherland JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1198-743X</gtr:issn><gtr:outcomeId>m1bfqvM6KEA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8FFE70F-90A3-46E7-930B-0FC75BF6BB65</gtr:id><gtr:title>Antibody and T-cell responses during acute and convalescent stages of invasive pneumococcal disease.</gtr:title><gtr:parentPublicationTitle>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbd9cb794d60ad6017c8b7d55cbd8f5d"><gtr:id>bbd9cb794d60ad6017c8b7d55cbd8f5d</gtr:id><gtr:otherNames>Ota MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1201-9712</gtr:issn><gtr:outcomeId>pm_23588_28_21330177</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCDAF31A-44F7-4FA3-9E16-8357DD79E817</gtr:id><gtr:title>Effect of Antiretroviral Therapy on HIV-mediated Impairment of the Neutrophil Antimycobacterial Response.</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fffeea0403dfb5c4fb207ad1992bd697"><gtr:id>fffeea0403dfb5c4fb207ad1992bd697</gtr:id><gtr:otherNames>Lowe DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn><gtr:outcomeId>56cf4a999e82e6.17197797</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C121B22C-6ADE-4AB1-9E40-8DF000011C06</gtr:id><gtr:title>Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dfbe18f3e93c5944ceac8518175a916"><gtr:id>4dfbe18f3e93c5944ceac8518175a916</gtr:id><gtr:otherNames>Martellet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>56cf4a462225e3.86597708</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>587AB44C-C04C-4B1E-8E41-23B05D67408B</gtr:id><gtr:title>Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB disease.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d833ab54d3476fbbf4b134f1f61b22df"><gtr:id>d833ab54d3476fbbf4b134f1f61b22df</gtr:id><gtr:otherNames>Awoniyi DO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>58aee1c3d0ed31.28339815</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_A900_1122</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>